1
|
Shirzadi Z, Boyle R, Yau WYW, Coughlan G, Fu JF, Properzi MJ, Buckley RF, Yang HS, Scanlon CE, Hsieh S, Amariglio RE, Papp K, Rentz D, Price JC, Johnson KA, Sperling RA, Chhatwal JP, Schultz AP. Vascular contributions to cognitive decline: Beyond amyloid and tau in the Harvard aging brain study. J Cereb Blood Flow Metab 2024:271678X241237624. [PMID: 38452039 DOI: 10.1177/0271678x241237624] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/09/2024]
Abstract
In addition to amyloid and tau pathology, elevated systemic vascular risk, white matter injury, and reduced cerebral blood flow contribute to late-life cognitive decline. Given the strong collinearity among these parameters, we proposed a framework to extract the independent latent features underlying cognitive decline using the Harvard Aging Brain Study (N = 166 cognitively unimpaired older adults at baseline). We used the following measures from the baseline visit: cortical amyloid, inferior temporal cortex tau, relative cerebral blood flow, white matter hyperintensities, peak width of skeletonized mean diffusivity, and Framingham Heart Study cardiovascular disease risk. We used exploratory factor analysis to extract orthogonal factors from these variables and their interactions. These factors were used in a regression model to explain longitudinal Preclinical Alzheimer Cognitive Composite-5 (PACC) decline (follow-up = 8.5 ±2.7 years). We next examined whether gray matter volume atrophy acts as a mediator of factors and PACC decline. Latent factors of systemic vascular risk, white matter injury, and relative cerebral blood flow independently explain cognitive decline beyond amyloid and tau. Gray matter volume atrophy mediates these associations with the strongest effect on white matter injury. These results suggest that systemic vascular risk contributes to cognitive decline beyond current markers of cerebrovascular injury, amyloid, and tau.
Collapse
Affiliation(s)
- Zahra Shirzadi
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Rory Boyle
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Wai-Ying W Yau
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Gillian Coughlan
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Jessie Fanglu Fu
- Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Michael J Properzi
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Rachel F Buckley
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Hyun-Sik Yang
- Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Catherine E Scanlon
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Stephanie Hsieh
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Rebecca E Amariglio
- Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Kathryn Papp
- Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Dorene Rentz
- Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Julie C Price
- Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Keith A Johnson
- Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Reisa A Sperling
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
- Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Jasmeer P Chhatwal
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Aaron P Schultz
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| |
Collapse
|
2
|
Weizenbaum EL, Soberanes D, Hsieh S, Molinare CP, Buckley RF, Betensky RA, Properzi MJ, Marshall GA, Rentz DM, Johnson KA, Sperling RA, Amariglio RE, Papp KV. Capturing learning curves with the multiday Boston Remote Assessment of Neurocognitive Health (BRANCH): Feasibility, reliability, and validity. Neuropsychology 2024; 38:198-210. [PMID: 37971862 PMCID: PMC10841660 DOI: 10.1037/neu0000933] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2023] Open
Abstract
OBJECTIVE Unsupervised remote digital cognitive assessment makes frequent testing feasible and allows for measurement of learning over repeated evaluations on participants' own devices. This provides the opportunity to derive individual multiday learning curve scores over short intervals. Here, we report feasibility, reliability, and validity, of a 7-day cognitive battery from the Boston Remote Assessment for Neurocognitive Health (Multiday BRANCH), an unsupervised web-based assessment. METHOD Multiday BRANCH was administered remotely to 181 cognitively unimpaired older adults using their own electronic devices. For 7 consecutive days, participants completed three tests with associative memory components (Face-Name, Groceries-Prices, Digit Signs), using the same stimuli, to capture multiday learning curves for each test. We assessed the feasibility of capturing learning curves across the 7 days. Additionally, we examined the reliability and associations of learning curves with demographics, and traditional cognitive and subjective report measures. RESULTS Multiday BRANCH was feasible with 96% of participants completing all study assessments; there were no differences dependent on type of device used (t = 0.71, p = .48) or time of day completed (t = -0.08, p = .94). Psychometric properties of the learning curves were sound including good test-retest reliability of individuals' curves (intraclass correlation = 0.94). Learning curves were positively correlated with in-person cognitive tests and subjective report of cognitive complaints. CONCLUSIONS Multiday BRANCH is a feasible, reliable, and valid cognitive measure that may be useful for identifying subtle changes in learning and memory processes in older adults. In the future, we will determine whether Multiday BRANCH is predictive of the presence of preclinical Alzheimer's disease. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
Collapse
Affiliation(s)
- Emma L Weizenbaum
- Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School
| | - Daniel Soberanes
- Department of Neurology, Brigham and Women's Hospital, Harvard Medical School
| | - Stephanie Hsieh
- Department of Neurology, Brigham and Women's Hospital, Harvard Medical School
| | - Cassidy P Molinare
- Department of Neurology, Brigham and Women's Hospital, Harvard Medical School
| | - Rachel F Buckley
- Department of Neurology, Brigham and Women's Hospital, Harvard Medical School
| | - Rebecca A Betensky
- Department of Biostatistics, School of Global Public Health, New York University
| | - Michael J Properzi
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School
| | - Gad A Marshall
- Department of Neurology, Brigham and Women's Hospital, Harvard Medical School
| | - Dorene M Rentz
- Department of Neurology, Brigham and Women's Hospital, Harvard Medical School
| | - Keith A Johnson
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School
| | - Reisa A Sperling
- Department of Neurology, Brigham and Women's Hospital, Harvard Medical School
| | - Rebecca E Amariglio
- Department of Neurology, Brigham and Women's Hospital, Harvard Medical School
| | - Kathryn V Papp
- Department of Neurology, Brigham and Women's Hospital, Harvard Medical School
| |
Collapse
|
3
|
Jutten RJ, Amariglio RE, Maruff P, Properzi MJ, Rentz DM, Johnson KA, Sperling RA, Papp KV. Increased intraindividual variability in reaction time performance is associated with emerging cognitive decline in cognitively unimpaired adults. Neuropsychology 2024; 38:184-197. [PMID: 37971861 DOI: 10.1037/neu0000928] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2023] Open
Abstract
OBJECTIVE To investigate whether intraindividual variability (IIV) in reaction time (RT) over monthly administered cognitive tasks is increased in cognitively unimpaired older adults who are at risk for cognitive decline, and whether this is independent of mean RT performance. METHOD N = 109 cognitively unimpaired individuals (age 77.4 ± 5.0, 61.5% female, Mini-Mental State Examination 29.1 ± 1.3) from the Harvard Aging Brain Study completed the self-administered Computerized Cognitive Composite (C3) monthly at home for up to 1 year (12.7 ± 3.2 C3 assessments). Baseline C3 assessment coincided with routine in-clinic visits, including amyloid and tau positron emission tomography imaging and standardized cognitive testing, with cognitive testing repeated annually (1.6 ± 1.2 years follow-up). The C3 includes two simple RT tasks and two complex RT tasks. IIV estimates were derived by computing intraindividual standard deviations on residual RT scores after regressing out age and session order effects. Cross-sectional associations of IIV with cognition (global cognition, memory, executive functions [EF], processing speed) and amyloid and tau burden were examined using linear regression analyses correcting for demographics and mean RT. The association between IIV and cognitive decline was assessed using linear mixed models correcting for demographic factors, mean RT, and amyloid burden. RESULTS After adjusting for mean RT, increased IIV on complex RT tasks was independently associated with worse EF performance (β = -0.10, 95% CI [-.16, -0.03], p = .004), greater inferior-temporal tau deposition (β = 0.18, 95% CI [0.02, 0.34], p = .024), and faster cognitive decline in those with elevated amyloid (β = -0.62, 95% CI [-1.18, -0.06], p = .033). CONCLUSIONS Increased variability in monthly RT may reflect subtle EF deficits and provide unique information about short-term cognitive decline in preclinical Alzheimer's disease. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
Collapse
Affiliation(s)
- Roos J Jutten
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School
| | - Rebecca E Amariglio
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School
| | | | - Michael J Properzi
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School
| | - Dorene M Rentz
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School
| | - Keith A Johnson
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School
| | - Reisa A Sperling
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School
| | - Kathryn V Papp
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School
| |
Collapse
|
4
|
Premnath PY, Locascio JJ, Mimmack KJ, Gonzalez C, Properzi MJ, Udeogu O, Rosenberg PB, Marshall GA, Gatchel JR. Longitudinal associations of apathy and regional tau in mild cognitive impairment and dementia: Findings from the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement (N Y) 2024; 10:e12442. [PMID: 38356477 PMCID: PMC10865481 DOI: 10.1002/trc2.12442] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/06/2023] [Revised: 12/06/2023] [Accepted: 12/10/2023] [Indexed: 02/16/2024]
Abstract
Introduction It is important to study apathy in Alzheimer's disease (AD) to better understand its underlying neurobiology and develop effective interventions. In the current study, we sought to examine the relationships between longitudinal apathy and regional tau burden in cognitively impaired older adults from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. Methods Three hundred and nineteen ADNI participants with mild cognitive impairment (MCI) or AD dementia underwent flortaucipir (FTP) tau positron emission tomography (PET) imaging and clinical assessment with the Neuropsychiatric Inventory (NPI) annually. Longitudinal NPI Apathy (NPI-A) scores were examined in relation to baseline tau PET signal in three a priori selected regions implicated in AD and AD-related apathy (supramarginal gyrus, entorhinal cortex [EC] and rostral anterior cingulate cortex [rACC]). Secondary models were adjusted for global cognition (Mini-Mental State Examination score) and cortical amyloid (florbetapir PET). Results Higher baseline supramarginal gyrus and EC tau burden were each significantly associated with greater NPI-A over time, while rACC tau was associated with higher NPI-A but did not predict its trajectory over time. These results were retained for supramarginal and EC tau after adjusting models for global cognition and cortical amyloid. Discussion Our findings suggest that baseline in vivo tau burden in parietal and temporal brain regions affected in AD, and less so in a medial frontal region involved in motivational control, is associated with increasing apathy over time in older adults with MCI and AD dementia. Future work studying emergent apathy in relation to not only core AD pathology but also circuit level dysfunction may provide additional insight into the neurobiology of apathy in AD and opportunities for intervention. Highlights Tau (Flortaucipir PET) in regions implicated in AD was associated with increasing apathy over timeCortical amyloid was also found to be a robust predictor of the trajectory of apathyEvidence of synergy between regional tau and amyloid in overall higher levels of apathy.
Collapse
Affiliation(s)
- Pranitha Y. Premnath
- Department of PsychologyThe Graduate Center, City University of New YorkNew YorkNew YorkUSA
| | - Joseph J. Locascio
- Department of NeurologyMassachusetts General HospitalBostonMassachusettsUSA
- Department of NeurologyHarvard Medical SchoolBostonMassachusettsUSA
| | - Kayden J. Mimmack
- Department of NeurologyMassachusetts General HospitalBostonMassachusettsUSA
| | | | - Michael J. Properzi
- Department of NeurologyMassachusetts General HospitalBostonMassachusettsUSA
- Department of NeurologyAthinoula A. Martinos Center for Biomedical ImagingCharlestownMassachusettsUSA
| | - Onyinye Udeogu
- Department of NeurologyMassachusetts General HospitalBostonMassachusettsUSA
| | - Paul B. Rosenberg
- Department of Psychiatry and Behavioral SciencesJohns Hopkins University School of MedicineBaltimoreMarylandUSA
| | - Gad A. Marshall
- Department of NeurologyMassachusetts General HospitalBostonMassachusettsUSA
- Department of NeurologyHarvard Medical SchoolBostonMassachusettsUSA
- Department of NeurologyBrigham and Women's HospitalBostonMassachusettsUSA
- Center for Alzheimer Research and TreatmentBrigham and Women's HospitalBostonMassachusettsUSA
| | - Jennifer R. Gatchel
- Division of Geriatric PsychiatryMcLean HospitalBelmontMassachusettsUSA
- Department of Psychiatry and Behavioral SciencesBaylor College of MedicineHoustonTexasUSA
- Department of Veterans AffairsMichael E. DeBakey VA Medical CenterHoustonTexasUSA
- Department of PsychiatryHarvard Medical SchoolBostonMassachusettsUSA
| | | |
Collapse
|
5
|
Scott MR, Edwards NC, Properzi MJ, Jacobs HIL, Price JC, Lois C, Farrell ME, Hanseeuw BJ, Thibault EG, Rentz DM, Johnson KA, Sperling RA, Schultz AP, Buckley RF. Contribution of extracerebral tracer retention and partial volume effects to sex differences in Flortaucipir-PET signal. J Cereb Blood Flow Metab 2024; 44:131-141. [PMID: 37728659 PMCID: PMC10905641 DOI: 10.1177/0271678x231196978] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/10/2023] [Revised: 05/24/2023] [Accepted: 06/22/2023] [Indexed: 09/21/2023]
Abstract
Clinically normal females exhibit higher 18F-flortaucipir (FTP)-PET signal than males across the cortex. However, these sex differences may be explained by neuroimaging idiosyncrasies such as off-target extracerebral tracer retention or partial volume effects (PVEs). 343 clinically normal participants (female = 58%; mean[SD]=73.8[8.5] years) and 55 patients with mild cognitive impairment (female = 38%; mean[SD] = 76.9[7.3] years) underwent cross-sectional FTP-PET. We parcellated extracerebral FreeSurfer areas based on proximity to cortical ROIs. Sex differences in cortical tau were then estimated after accounting for local extracerebral retention. We simulated PVE by convolving group-level standardized uptake value ratio means in each ROI with 6 mm Gaussian kernels and compared the sexes across ROIs post-smoothing. Widespread sex differences in extracerebral retention were observed. Although attenuating sex differences in cortical tau-PET signal, covarying for extracerebral retention did not impact the largest sex differences in tau-PET signal. Differences in PVE were observed in both female and male directions with no clear sex-specific bias. Our findings suggest that sex differences in FTP are not solely attributed to off-target extracerebral retention or PVE, consistent with the notion that sex differences in medial temporal and neocortical tau are biologically driven. Future work should investigate sex differences in regional cerebral blood flow kinetics and longitudinal tau-PET.
Collapse
Affiliation(s)
- Matthew R Scott
- Department of Neurology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
- Department of Biostatistics, School of Public Health, Boston University, Boston, MA, USA
| | - Natalie C Edwards
- Department of Neurology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
- Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia University, New York City, NY, USA
- Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY, USA
| | - Michael J Properzi
- Department of Neurology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
| | - Heidi IL Jacobs
- Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
- Faculty of Health, Medicine and Life Sciences, School for Mental Health and Neuroscience, Alzheimer Centre Limburg, Maastricht University, Maastricht, The Netherlands
| | - Julie C Price
- Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
| | - Cristina Lois
- Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
| | - Michelle E Farrell
- Department of Neurology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
| | - Bernard J Hanseeuw
- Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
- Department of Neurology, Cliniques Universitaires SaintLuc, Institute of Neuroscience, Université Catholique de Louvain, Brussels, Belgium
| | - Emma G Thibault
- Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
| | - Dorene M Rentz
- Department of Neurology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
- Department of Neurology, Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Boston, MA, USA
| | - Keith A Johnson
- Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
- Department of Neurology, Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Boston, MA, USA
| | - Reisa A Sperling
- Department of Neurology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
- Department of Neurology, Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Boston, MA, USA
| | - Aaron P Schultz
- Department of Neurology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
| | - Rachel F Buckley
- Department of Neurology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
- Department of Neurology, Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Boston, MA, USA
- Melbourne School of Psychological Science, University of Melbourne, Melbourne, VIC, Australia
| |
Collapse
|
6
|
Gagliardi G, Rodriguez-Vieitez E, Montal V, Sepulcre J, Diez I, Lois C, Hanseeuw B, Schultz AP, Properzi MJ, Papp KV, Marshall GA, Fortea J, Johnson KA, Sperling RA, Vannini P. Cortical microstructural changes predict tau accumulation and episodic memory decline in older adults harboring amyloid. Commun Med (Lond) 2023; 3:106. [PMID: 37528163 PMCID: PMC10394044 DOI: 10.1038/s43856-023-00324-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2023] [Accepted: 06/19/2023] [Indexed: 08/03/2023] Open
Abstract
INTRODUCTION Non-invasive diffusion-weighted imaging (DWI) to assess brain microstructural changes via cortical mean diffusivity (cMD) has been shown to be cross-sectionally associated with tau in cognitively normal older adults, suggesting that it might be an early marker of neuronal injury. Here, we investigated how regional cortical microstructural changes measured by cMD are related to the longitudinal accumulation of regional tau as well as to episodic memory decline in cognitively normal individuals harboring amyloid pathology. METHODS 122 cognitively normal participants from the Harvard Aging Brain Study underwent DWI, T1w-MRI, amyloid and tau PET imaging, and Logical Memory Delayed Recall (LMDR) assessments. We assessed whether the interaction of baseline amyloid status and cMD (in entorhinal and inferior-temporal cortices) was associated with longitudinal regional tau accumulation and with longitudinal LMDR using separate linear mixed-effects models. RESULTS We find a significant interaction effect of the amyloid status and baseline cMD in predicting longitudinal tau in the entorhinal cortex (p = 0.044) but not the inferior temporal lobe, such that greater baseline cMD values predicts the accumulation of entorhinal tau in amyloid-positive participants. Moreover, we find a significant interaction effect of the amyloid status and baseline cMD in the entorhinal cortex (but not inferior temporal cMD) in predicting longitudinal LMDR (p < 0.001), such that baseline entorhinal cMD predicts the episodic memory decline in amyloid-positive participants. CONCLUSIONS The combination of amyloidosis and elevated cMD in the entorhinal cortex may help identify individuals at short-term risk of tau accumulation and Alzheimer's Disease-related episodic memory decline, suggesting utility in clinical trials.
Collapse
Affiliation(s)
- Geoffroy Gagliardi
- Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA
- Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, 02129, USA
- Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA
| | - Elena Rodriguez-Vieitez
- Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA
- Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, 02129, USA
- Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, Stockholm, 14152, Sweden
| | - Victor Montal
- Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, 08041, Spain
- Centre of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, 28031, Spain
| | - Jorge Sepulcre
- Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA
- Gordon Center for Medical Imaging, Boston, MA, 02114, USA
| | - Ibai Diez
- Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA
- Gordon Center for Medical Imaging, Boston, MA, 02114, USA
| | - Cristina Lois
- Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA
- Gordon Center for Medical Imaging, Boston, MA, 02114, USA
| | - Bernard Hanseeuw
- Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA
- Gordon Center for Medical Imaging, Boston, MA, 02114, USA
- Saint Luc University Hospital, Université Catholique de Louvain, Brussels, 1200, Belgium
| | - Aaron P Schultz
- Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA
- Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, 02129, USA
| | - Michael J Properzi
- Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA
| | - Kathryn V Papp
- Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA
- Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, 02129, USA
- Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA
| | - Gad A Marshall
- Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA
- Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA
| | - Juan Fortea
- Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, 08041, Spain
- Centre of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, 28031, Spain
| | - Keith A Johnson
- Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA
- Gordon Center for Medical Imaging, Boston, MA, 02114, USA
| | - Reisa A Sperling
- Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA
- Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, 02129, USA
- Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA
| | - Patrizia Vannini
- Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
- Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, 02129, USA.
- Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
| |
Collapse
|
7
|
Hampton OL, Mukherjee S, Properzi MJ, Schultz AP, Crane PK, Gibbons LE, Hohman TJ, Maruff P, Lim YY, Amariglio RE, Papp KV, Johnson KA, Rentz DM, Sperling RA, Buckley RF. Harmonizing the preclinical Alzheimer cognitive composite for multicohort studies. Neuropsychology 2023; 37:436-449. [PMID: 35862098 PMCID: PMC9859944 DOI: 10.1037/neu0000833] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023] Open
Abstract
OBJECTIVES Studies are increasingly examining research questions across multiple cohorts using data from the preclinical Alzheimer cognitive composite (PACC). Our objective was to use modern psychometric approaches to develop a harmonized PACC. METHOD We used longitudinal data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), Harvard Aging Brain Study (HABS), and Australian Imaging, Biomarker and Lifestyle Study of Ageing (AIBL) cohorts (n = 2,712). We further demonstrated our method with the Anti-Amyloid Treatment of Asymptomatic Alzheimer's Disease (A4) Study prerandomized data (n = 4,492). For the harmonization method, we used confirmatory factor analysis (CFA) on the final visit of the longitudinal cohorts to determine parameters to generate latent PACC (lPACC) scores. Overlapping tests across studies were set as "anchors" that tied cohorts together, while parameters from unique tests were freely estimated. We performed validation analyses to assess the performance of lPACC versus the common standardized PACC (zPACC). RESULTS Baseline (BL) scores for the zPACC were centered on zero, by definition. The harmonized lPACC did not define a common mean of zero and demonstrated differences in baseline ability levels across the cohorts. Baseline lPACC slightly outperformed zPACC in the prediction of progression to dementia. Longitudinal change in the lPACC was more constrained and less variable relative to the zPACC. In combined-cohort analyses, longitudinal lPACC slightly outperformed longitudinal zPACC in its association with baseline β-amyloid status. CONCLUSIONS This study proposes procedures for harmonizing the PACC that make fewer strong assumptions than the zPACC, facilitating robust multicohort analyses. This implementation of item response theory lends itself to adapting across future cohorts with similar composites. (PsycInfo Database Record (c) 2023 APA, all rights reserved).
Collapse
Affiliation(s)
- Olivia L. Hampton
- Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, United States
| | - Shubhabrata Mukherjee
- Department of Medicine, Division of General Internal Medicine, University of Washington
| | - Michael J. Properzi
- Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, United States
| | - Aaron P. Schultz
- Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, United States
| | - Paul K. Crane
- Department of Medicine, Division of General Internal Medicine, University of Washington
| | - Laura E. Gibbons
- Department of Medicine, Division of General Internal Medicine, University of Washington
| | - Timothy J. Hohman
- Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee, United States
| | - Paul Maruff
- Cogstate Ltd., Melbourne, Victoria, Australia
| | - Yen Ying Lim
- Turner Institute for Brain and Mental Health, Monash University, Melbourne, Victoria, Australia
| | - Rebecca E. Amariglio
- Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, United States
- Department of Neurology, Brigham and Women’s Hospital, Center for Alzheimer Research and Treatment, Boston, Massachusetts, United States
| | - Kathryn V. Papp
- Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, United States
- Department of Neurology, Brigham and Women’s Hospital, Center for Alzheimer Research and Treatment, Boston, Massachusetts, United States
| | - Keith A. Johnson
- Department of Neurology, Brigham and Women’s Hospital, Center for Alzheimer Research and Treatment, Boston, Massachusetts, United States
- Department of Radiology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, United States
| | - Dorene M. Rentz
- Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, United States
- Department of Neurology, Brigham and Women’s Hospital, Center for Alzheimer Research and Treatment, Boston, Massachusetts, United States
| | - Reisa A. Sperling
- Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, United States
- Department of Neurology, Brigham and Women’s Hospital, Center for Alzheimer Research and Treatment, Boston, Massachusetts, United States
| | - Rachel F. Buckley
- Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, United States
- Department of Neurology, Brigham and Women’s Hospital, Center for Alzheimer Research and Treatment, Boston, Massachusetts, United States
- Melbourne School of Psychological Science, University of Melbourne
| |
Collapse
|
8
|
Coughlan GT, Betthauser TJ, Boyle R, Koscik RL, Klinger HM, Chibnik LB, Jonaitis EM, Yau WYW, Wenzel A, Christian BT, Gleason CE, Saelzler UG, Properzi MJ, Schultz AP, Hanseeuw BJ, Manson JE, Rentz DM, Johnson KA, Sperling R, Johnson SC, Buckley RF. Association of Age at Menopause and Hormone Therapy Use With Tau and β-Amyloid Positron Emission Tomography. JAMA Neurol 2023; 80:462-473. [PMID: 37010830 PMCID: PMC10071399 DOI: 10.1001/jamaneurol.2023.0455] [Citation(s) in RCA: 23] [Impact Index Per Article: 23.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2022] [Accepted: 12/16/2022] [Indexed: 04/04/2023]
Abstract
Importance Postmenopausal females represent around 70% of all individuals with Alzheimer disease. Previous literature shows elevated levels of tau in cognitively unimpaired postmenopausal females compared with age-matched males, particularly in the setting of high β-amyloid (Aβ). The biological mechanisms associated with higher tau deposition in female individuals remain elusive. Objective To examine the extent to which sex, age at menopause, and hormone therapy (HT) use are associated with regional tau at a given level of Aβ, both measured with positron emission tomography (PET). Design, Setting, and Participants This cross-sectional study included participants enrolled in the Wisconsin Registry for Alzheimer Prevention. Cognitively unimpaired males and females with at least 1 18F-MK-6240 and 11C-Pittsburgh compound B PET scan were analyzed. Data were collected between November 2006 and May 2021. Exposures Premature menopause (menopause at younger than 40 years), early menopause (menopause at age 40-45 years), and regular menopause (menopause at older than 45 years) and HT user (current/past use) and HT nonuser (no current/past use). Exposures were self-reported. Main Outcomes and Measures Seven tau PET regions that show sex differences across temporal, parietal, and occipital lobes. Primary analyses examined the interaction of sex, age at menopause or HT, and Aβ PET on regional tau PET in a series of linear regressions. Secondary analyses investigated the influence of HT timing in association with age at menopause on regional tau PET. Results Of 292 cognitively unimpaired individuals, there were 193 females (66.1%) and 99 males (33.9%). The mean (range) age at tau scan was 67 (49-80) years, 52 (19%) had abnormal Aβ, and 106 (36.3%) were APOEε4 carriers. There were 98 female HT users (52.2%) (past/current). Female sex (standardized β = -0.41; 95% CI, -0.97 to -0.32; P < .001), earlier age at menopause (standardized β = -0.38; 95% CI, -0.14 to -0.09; P < .001), and HT use (standardized β = 0.31; 95% CI, 0.40-1.20; P = .008) were associated with higher regional tau PET in individuals with elevated Aβ compared with male sex, later age at menopause, and HT nonuse. Affected regions included medial and lateral regions of the temporal and occipital lobes. Late initiation of HT (>5 years following age at menopause) was associated with higher tau PET compared with early initiation (β = 0.49; 95% CI, 0.27-0.43; P = .001). Conclusions and Relevance In this study, females exhibited higher tau compared with age-matched males, particularly in the setting of elevated Aβ. In females, earlier age at menopause and late initiation of HT were associated with increased tau vulnerability especially when neocortical Aβ elevated. These observational findings suggest that subgroups of female individuals may be at higher risk of pathological burden.
Collapse
Affiliation(s)
- Gillian T. Coughlan
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston
| | - Tobey J. Betthauser
- Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin, School of Medicine and Public Health, Madison
- Department of Medicine, University of Wisconsin–Madison, Madison
| | - Rory Boyle
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston
| | - Rebecca L. Koscik
- Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin, School of Medicine and Public Health, Madison
- Department of Medicine, University of Wisconsin–Madison, Madison
| | - Hannah M. Klinger
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston
| | - Lori B. Chibnik
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston
- Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, and the Harvard T.H. Chan School of Public Health, Boston, Massachusetts
| | - Erin M. Jonaitis
- Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin, School of Medicine and Public Health, Madison
- Department of Medicine, University of Wisconsin–Madison, Madison
| | - Wai-Ying Wendy Yau
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston
| | - Allen Wenzel
- Department of Medicine, University of Wisconsin–Madison, Madison
| | - Bradley T. Christian
- Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin, School of Medicine and Public Health, Madison
| | - Carey E. Gleason
- Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin, School of Medicine and Public Health, Madison
| | - Ursula G. Saelzler
- Department of Psychiatry, University of California, San Diego, San Diego
| | - Michael J. Properzi
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston
| | - Aaron P. Schultz
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston
- Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Boston, Massachusetts
| | - Bernard J. Hanseeuw
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston
- Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Boston, Massachusetts
- Department of Neurology, Cliniques Universitaires Saint-Luc, Woluwe-Saint-Lambert, Belgium
- Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston
- Institute of Neuroscience, Université Catholique de Louvain, Brussels, Belgium
| | - JoAnn E. Manson
- Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, and the Harvard T.H. Chan School of Public Health, Boston, Massachusetts
| | - Dorene M. Rentz
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston
- Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Boston, Massachusetts
| | - Keith A. Johnson
- Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Boston, Massachusetts
- Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston
| | - Reisa Sperling
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston
- Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Boston, Massachusetts
| | - Sterling C. Johnson
- Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin, School of Medicine and Public Health, Madison
- Department of Medicine, University of Wisconsin–Madison, Madison
| | - Rachel F. Buckley
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston
- Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Boston, Massachusetts
- Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Victoria, Australia
| |
Collapse
|
9
|
Gonzalez C, Mimmack KJ, Amariglio RE, Becker JA, Chhatwal JP, Fitzpatrick CD, Gatchel JR, Johnson KA, Katz ZS, Kuppe MK, Locascio JJ, Udeogu OJ, Papp KV, Premnath P, Properzi MJ, Rentz DM, Schultz AP, Sperling RA, Vannini P, Wang S, Marshall GA. Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings. J Alzheimers Dis 2023; 94:217-226. [PMID: 37212093 PMCID: PMC10330453 DOI: 10.3233/jad-220885] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
BACKGROUND Detecting clinically meaningful changes in instrumental activities of daily living (IADL) at the earliest stages of Alzheimer's disease (AD) is critical. OBJECTIVE The objective of this exploratory study was to examine the cross-sectional relationship between a performance-based IADL test, the Harvard Automated Phone Task (APT), and cerebral tau and amyloid burden in cognitively normal (CN) older adults. METHODS Seventy-seven CN participants underwent flortaucipir tau and Pittsburgh Compound B amyloid PET. IADL were assessed using the three Harvard APT tasks: prescription refill (APT-Script), health insurance company call (APT-PCP), and bank transaction (APT-Bank). Linear regression models were used to determine associations between each APT task and entorhinal cortex, inferior temporal, or precuneus tau with or without an interaction with amyloid. RESULTS Significant associations were found between APT-Bank task rate and interaction between amyloid and entorhinal cortex tau, and APT-PCP task and interactions between amyloid and inferior temporal and precuneus tau. No significant associations were found between the APT tasks and tau or amyloid alone. CONCLUSION Our preliminary findings suggest an association between a simulated real-life IADL test and interactions of amyloid and several regions of early tau accumulation in CN older adults. However, some analyses were underpowered due to the small number of participants with elevated amyloid, and findings should be interpreted with caution. Future studies will further explore these associations cross-sectionally and longitudinally in order to determine whether the Harvard APT can serve as a reliable IADL outcome measure for preclinical AD prevention trials and ultimately in the clinic setting.
Collapse
Affiliation(s)
- Christopher Gonzalez
- Department of Psychology, Illinois Institute of Technology,
Chicago, IL 60616, USA
| | - Kayden J. Mimmack
- Department of Neurology, Massachusetts General Hospital,
Harvard Medical School, Boston, MA 02114, USA
| | - Rebecca E. Amariglio
- Department of Neurology, Massachusetts General Hospital,
Harvard Medical School, Boston, MA 02114, USA
- Center for Alzheimer Research and Treatment, Brigham and
Women’s Hospital, Harvard Medical School, Boston, MA, 02115, USA
- Department of Neurology, Brigham and Women’s
Hospital, Harvard Medical School, Boston, MA, 02115, USA
| | - J. Alex Becker
- Department of Radiology, Massachusetts General Hospital,
Harvard Medical School, Boston, MA 02114, USA
| | - Jasmeer P. Chhatwal
- Department of Neurology, Massachusetts General Hospital,
Harvard Medical School, Boston, MA 02114, USA
- Center for Alzheimer Research and Treatment, Brigham and
Women’s Hospital, Harvard Medical School, Boston, MA, 02115, USA
- Department of Neurology, Brigham and Women’s
Hospital, Harvard Medical School, Boston, MA, 02115, USA
| | - Colleen D. Fitzpatrick
- Department of Neurology, Massachusetts General Hospital,
Harvard Medical School, Boston, MA 02114, USA
| | - Jennifer R. Gatchel
- Department of Psychiatry, Massachusetts General Hospital,
Harvard Medical School, Boston, MA 02114, USA
- Division of Geriatric Psychiatry, McLean Hospital, Harvard
Medical School, Belmont, MA 02478, USA
| | - Keith A. Johnson
- Department of Neurology, Massachusetts General Hospital,
Harvard Medical School, Boston, MA 02114, USA
- Department of Radiology, Massachusetts General Hospital,
Harvard Medical School, Boston, MA 02114, USA
- Center for Alzheimer Research and Treatment, Brigham and
Women’s Hospital, Harvard Medical School, Boston, MA, 02115, USA
- Department of Neurology, Brigham and Women’s
Hospital, Harvard Medical School, Boston, MA, 02115, USA
| | - Zoe S. Katz
- Department of Neurology, Massachusetts General Hospital,
Harvard Medical School, Boston, MA 02114, USA
| | - Madeline K. Kuppe
- Cognitive Neuroimaging Laboratory, Graduate Program for
Neuroscience, Boston University, Boston, MA 02215, USA
| | - Joseph J. Locascio
- Department of Neurology, Massachusetts General Hospital,
Harvard Medical School, Boston, MA 02114, USA
| | - Onyinye J. Udeogu
- Department of Neurology, Massachusetts General Hospital,
Harvard Medical School, Boston, MA 02114, USA
| | - Kathryn V. Papp
- Department of Neurology, Massachusetts General Hospital,
Harvard Medical School, Boston, MA 02114, USA
- Center for Alzheimer Research and Treatment, Brigham and
Women’s Hospital, Harvard Medical School, Boston, MA, 02115, USA
- Department of Neurology, Brigham and Women’s
Hospital, Harvard Medical School, Boston, MA, 02115, USA
| | - Pranitha Premnath
- Department of Psychology, The Graduate Center, City
University of New York, New York, NY 10016, USA
| | - Michael J. Properzi
- Department of Neurology, Massachusetts General Hospital,
Harvard Medical School, Boston, MA 02114, USA
| | - Dorene M. Rentz
- Department of Neurology, Massachusetts General Hospital,
Harvard Medical School, Boston, MA 02114, USA
- Center for Alzheimer Research and Treatment, Brigham and
Women’s Hospital, Harvard Medical School, Boston, MA, 02115, USA
- Department of Neurology, Brigham and Women’s
Hospital, Harvard Medical School, Boston, MA, 02115, USA
| | - Aaron P. Schultz
- Department of Neurology, Massachusetts General Hospital,
Harvard Medical School, Boston, MA 02114, USA
| | - Reisa A. Sperling
- Department of Neurology, Massachusetts General Hospital,
Harvard Medical School, Boston, MA 02114, USA
- Center for Alzheimer Research and Treatment, Brigham and
Women’s Hospital, Harvard Medical School, Boston, MA, 02115, USA
- Department of Neurology, Brigham and Women’s
Hospital, Harvard Medical School, Boston, MA, 02115, USA
| | - Patrizia Vannini
- Department of Neurology, Massachusetts General Hospital,
Harvard Medical School, Boston, MA 02114, USA
- Center for Alzheimer Research and Treatment, Brigham and
Women’s Hospital, Harvard Medical School, Boston, MA, 02115, USA
- Department of Neurology, Brigham and Women’s
Hospital, Harvard Medical School, Boston, MA, 02115, USA
| | - Sharon Wang
- Department of Neurology, Massachusetts General Hospital,
Harvard Medical School, Boston, MA 02114, USA
| | - Gad A. Marshall
- Department of Neurology, Massachusetts General Hospital,
Harvard Medical School, Boston, MA 02114, USA
- Center for Alzheimer Research and Treatment, Brigham and
Women’s Hospital, Harvard Medical School, Boston, MA, 02115, USA
- Department of Neurology, Brigham and Women’s
Hospital, Harvard Medical School, Boston, MA, 02115, USA
| |
Collapse
|
10
|
Jutten RJ, Rentz DM, Amariglio RE, Properzi MJ, Maruff P, Johnson KA, Sperling RA, Papp KV. Fluctuations in reaction time performance as a marker of incipient amyloid‐related cognitive decline in clinically unimpaired older adults. Alzheimers Dement 2022. [DOI: 10.1002/alz.066578] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Roos J. Jutten
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Dorene M. Rentz
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Brigham and Women’s Hospital, Harvard Medical School Boston MA USA
| | - Rebecca E. Amariglio
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Brigham and Women’s Hospital, Harvard Medical School Boston MA USA
| | | | - Paul Maruff
- Cogstate Ltd. Melbourne VIC Australia
- The Florey Institute of Neuroscience and Mental Health Melbourne VIC Australia
| | - Keith A. Johnson
- Massachusetts General Hospital, Brigham and Women’s Hospital,Harvard Medical School Boston MA USA
| | - Reisa A. Sperling
- Brigham and Women’s Hospital, Harvard Medical School Boston MA USA
- Massachusetts General Hospital, Brigham and Women’s Hospital,Harvard Medical School Boston MA USA
| | - Kathryn V. Papp
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Brigham and Women’s Hospital, Harvard Medical School Boston MA USA
| |
Collapse
|
11
|
Farrell ME, Thibault EG, Becker A, Price JC, Schultz AP, Properzi MJ, Buckley RF, Jacobs HI, Hanseeuw B, Sperling RA, Johnson KA. Optimizing early detection of beta‐amyloid accumulation with PET using spatial extent. Alzheimers Dement 2022. [DOI: 10.1002/alz.068029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
| | - Emma G. Thibault
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Alex Becker
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Julie C Price
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Aaron P. Schultz
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | - Rachel F. Buckley
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Melbourne School of Psychological Sciences, University of Melbourne Melbourne VIC Australia
- Center for Alzheimer’s Research and Treatment, Brigham and Women’s Hospital/Harvard Medical School Boston MA USA
- The Florey Institute of Neuroscience and Mental Health Parkville Australia
| | - Heidi I.L. Jacobs
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Bernard Hanseeuw
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Institute of Neuroscience, Université Catholique de Louvain Brussels Belgium
| | - Reisa A. Sperling
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Center for Alzheimer’s Research and Treatment, Brigham and Women’s Hospital/Harvard Medical School Boston MA USA
| | - Keith A. Johnson
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| |
Collapse
|
12
|
Coughlan GT, Koscik RL, Betthauser TJ, Boyle RT, Jonaitis EM, Wenzel A, Christian BT, Gleason CE, Klinger H, Properzi MJ, Schultz AP, Hanseeuw BJ, Rentz DM, Johnson KA, Sperling RA, Johnson SC, Buckley RF. Menopause age and hormone therapy use moderate PET tau and amyloid association: findings from the Wisconsin Registry for Alzheimer Prevention. Alzheimers Dement 2022. [DOI: 10.1002/alz.062007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
| | | | - Tobey J Betthauser
- School of Medicine and Public Health, University of Wisconsin‐Madison Madison WI USA
| | - Rory Thomas Boyle
- Harvard Medical School, Massachusetts General Hospital Boston MA USA
| | - Erin M. Jonaitis
- Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health Madison WI USA
| | | | - Bradley T Christian
- Department of Medical Physics, University of Wisconsin‐Madison School of Medicine and Public Health Madison WI USA
| | - Carey E. Gleason
- University of Wisconsin School of Medicine and Public Health Alzheimer's Disease Research Center Madison WI USA
| | - Hannah Klinger
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | - Aaron P. Schultz
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Bernard J Hanseeuw
- Institute of Neuroscience, UCLouvain Brussels Belgium
- Massachussets General Hospital, Harvard Medical School Boston USA
| | - Dorene M. Rentz
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Keith A. Johnson
- Massachusetts General Hospital, Brigham and Women’s Hospital,Harvard Medical School Boston MA USA
| | - Reisa A. Sperling
- Massachusetts General Hospital, Brigham and Women’s Hospital,Harvard Medical School Boston MA USA
| | - Sterling C. Johnson
- University of Wisconsin‐Madison School of Medicine and Public Health Madison WI USA
| | - Rachel F. Buckley
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| |
Collapse
|
13
|
Yau WW, Shirzadi Z, Rabin JS, Properzi MJ, Schultz AP, Rentz DM, Johnson KA, Sperling RA, Chhatwal JP. Longitudinal tau burden partially mediates synergistic influence of vascular risk and amyloid‐beta on cognitive decline in clinically normal older adults. Alzheimers Dement 2022. [DOI: 10.1002/alz.068274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
| | - Zahra Shirzadi
- Massachusetts General Hospital, Brigham and Women’s Hospital,Harvard Medical School Boston MA USA
| | | | | | - Aaron P. Schultz
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Dorene M. Rentz
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| | - Keith A. Johnson
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| | - Reisa A. Sperling
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| | - Jasmeer P. Chhatwal
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| |
Collapse
|
14
|
Shirzadi Z, Yau WW, Rabin JS, Buckley RF, Properzi MJ, Fu JF, Hsieh S, Thibault EG, Mojiri‐Forooshani P, Goubran M, MacIntosh BJ, Black SE, Price JC, Johnson KA, Sperling RA, Chhatwal JP, Schultz AP. Cerebrovascular injury markers explain the effect of systemic vascular risk on cognitive decline in older adults with lower amyloid burden. Alzheimers Dement 2022. [DOI: 10.1002/alz.066686] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Zahra Shirzadi
- Massachusetts General Hospital, Brigham and Women’s Hospital, Harvard Medical School Boston MA USA
| | | | | | - Rachel F. Buckley
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | | | - Stephanie Hsieh
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Emma G. Thibault
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | - Maged Goubran
- Sunnybrook Research Institute, University of Toronto Toronto ON Canada
| | | | - Sandra E. Black
- Sunnybrook Research Institute, University of Toronto Toronto ON Canada
| | - Julie C Price
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Keith A. Johnson
- Massachusetts General Hospital, Brigham and Women’s Hospital, Harvard Medical School Boston MA USA
| | - Reisa A. Sperling
- Massachusetts General Hospital, Brigham and Women’s Hospital, Harvard Medical School Boston MA USA
| | | | - Aaron P. Schultz
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| |
Collapse
|
15
|
Hanseeuw B, Jacobs HI, Schultz AP, Buckley RF, Properzi MJ, Becker A, Farrell ME, Sanchez JS, Papp KV, Yang H, Chhatwal JP, Price JC, Fakhri GE, Rentz DM, Sperling RA, Johnson KA. Longitudinal hippocampal atrophy is associated with cognitive decline independently of amyloid and tau in neocortex. Alzheimers Dement 2022. [DOI: 10.1002/alz.069271] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Bernard Hanseeuw
- Saint Luc University Hospital, Université Catholique de Louvain Brussels Belgium
- Gordon Center for Medical Imaging, Radiology Department, Massachusetts General Hospital Boston MA USA
| | - Heidi I.L. Jacobs
- Faculty of Health, Medicine and Life Sciences, School for Mental Health and Neuroscience, Alzheimer Centre Limburg, Maastricht University Maastricht Netherlands
- Gordon Center for Medical Imaging, Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Aaron P Schultz
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Rachel F. Buckley
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | - Alex Becker
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | - Justin S Sanchez
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Washington University School of Medicine St. Louis MO USA
| | - Kathryn V. Papp
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Hyun‐Sik Yang
- Massachusetts General Hospital/Harvard Medical School Boston MA USA
| | | | - Julie C Price
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Georges El Fakhri
- Gordon Center for Medical Imaging, Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Dorene M. Rentz
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Reisa A. Sperling
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Keith A. Johnson
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| |
Collapse
|
16
|
Yang H, Teng L, Kang D, Menon V, Ge T, Finucane H, Schultz AP, Properzi MJ, Klein H, Chibnik LB, Schneider JA, Bennett DA, Hohman TJ, Mayeux R, Johnson KA, De Jager PL, Sperling RA. Microglia‐specific Alzheimer’s disease polygenic risk score is associated with amyloid‐β, tau, and microglial activation. Alzheimers Dement 2022. [DOI: 10.1002/alz.061819] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Hyun‐Sik Yang
- Brigham and Women’s Hospital Boston MA USA
- Broad Institute of MIT and Harvard Cambridge MA USA
- Massachusetts General Hospital Boston MA USA
- Harvard Medical School Boston MA USA
| | - Ling Teng
- Brigham and Women’s Hospital Boston MA USA
- Broad Institute of MIT and Harvard CAMBRIDGE MA USA
| | - Daniel Kang
- Massachusetts General Hospital Boston MA USA
| | - Vilas Menon
- Columbia University Irving Medical Center New York NY USA
| | - Tian Ge
- Massachusetts General Hospital Boston MA USA
- Harvard Medical School Boston MA USA
| | - Hilary Finucane
- Broad Institute of MIT and Harvard Cambridge MA USA
- Massachusetts General Hospital Boston MA USA
- Harvard Medical School Boston MA USA
| | - Aaron P. Schultz
- Massachusetts General Hospital Boston MA USA
- Harvard Medical School Boston MA USA
| | - Michael J Properzi
- Massachusetts General Hospital Boston MA USA
- Harvard Medical School Boston MA USA
| | | | - Lori B. Chibnik
- Broad Institute of MIT and Harvard Cambridge MA USA
- Massachusetts General Hospital Boston MA USA
- Harvard Medical School Boston MA USA
- Harvard T.H. Chan School of Public Health Boston MA USA
| | | | | | | | - Richard Mayeux
- Columbia University Irving Medical Center New York NY USA
| | - Keith A. Johnson
- Massachusetts General Hospital Boston MA USA
- Harvard Medical School Boston MA USA
- Center for Alzheimer’s Research and Treatment, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School Boston MA USA
| | | | - Reisa A. Sperling
- Brigham and Women’s Hospital Boston MA USA
- Massachusetts General Hospital Boston MA USA
- Harvard Medical School Boston MA USA
| |
Collapse
|
17
|
Boyle RT, Coughlan GT, Properzi MJ, Archdeacon C, Chou HL, Klinger H, Jacobs HI, Papp KV, Amariglio RE, Farrell ME, Donohue MC, Hohman TJ, Mormino EC, Hanseeuw BJ, Chhatwal JP, Rentz DM, Price JC, Johnson KA, Schultz AP, Sperling RA, Buckley RF. Defining the ATN framework using longitudinal biomarker trajectories reveals an emerging amyloid accumulation group. Alzheimers Dement 2022. [DOI: 10.1002/alz.068001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Rory Thomas Boyle
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | | | - Claire Archdeacon
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | - Hannah Klinger
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Heidi I.L. Jacobs
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Kathryn V. Papp
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | | | - Michael C. Donohue
- Alzheimer's Therapeutic Research Institute, Keck School of Medicine, University of Southern California San Diego CA USA
| | - Timothy J. Hohman
- Vanderbilt Memory & Alzheimer’s Center, Vanderbilt University Medical Center Nashville TN USA
| | | | | | | | - Dorene M. Rentz
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Julie C Price
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Keith A. Johnson
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Aaron P. Schultz
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Reisa A. Sperling
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Rachel F. Buckley
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | |
Collapse
|
18
|
Gagliardi GP, Rodriguez‐Vieitez E, Montal V, Sepulcre J, Diez IP, Lois C, Hanseeuw B, Schultz AP, Properzi MJ, Papp KV, Marshall GA, Fortea J, Johnson KA, Sperling RA, Vannini P. The role of cortical microstructural changes on longitudinal accumulation of tau and cognitive decline in at risk older adults. Alzheimers Dement 2022. [DOI: 10.1002/alz.065744] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Geoffroy Pierre Gagliardi
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| | - Elena Rodriguez‐Vieitez
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Karolinska Institutet Stockholm Sweden
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
| | - Victor Montal
- Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED) Madrid Spain
- Sant Pau Memory Unit, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona Barcelona Spain
| | - Jorge Sepulcre
- Massachusetts General Hospital, Harvard Medical School, Department of Neurology, Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Gordon Center for Medical Imaging Boston MA USA
| | - Ibai Palacio Diez
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Boston MA USA
| | - Cristina Lois
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Gordon Center for Medical Imaging Boston MA USA
| | - Bernard Hanseeuw
- Gordon Center for Medical Imaging Boston MA USA
- Massachusetts General Hospital Boston MA USA
- Saint Luc University Hospital, Université Catholique de Louvain Brussels Belgium
| | - Aaron P. Schultz
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging, Harvard Medical School Charlestown MA USA
| | | | - Kathryn V. Papp
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
| | - Gad A Marshall
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
| | - Juan Fortea
- Sant Pau Memory Unit, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona Barcelona Spain
- Centre of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED) Madrid Spain
| | - Keith A. Johnson
- Gordon Center for Medical Imaging Boston MA USA
- Massachusetts General Hospital, Brigham and Women’s Hospital, Harvard Medical School Boston MA USA
| | - Reisa A. Sperling
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Massachusetts General Hospital, Brigham and Women’s Hospital, Harvard Medical School Boston MA USA
| | - Patrizia Vannini
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
| |
Collapse
|
19
|
Yau WW, Shirzadi Z, Rabin JS, Properzi MJ, Schultz AP, Rentz DM, Johnson KA, Sperling RA, Chhatwal JP. Longitudinal tau burden partially mediates synergistic influence of vascular risk and amyloid‐beta on cognitive decline in clinically normal older adults. Alzheimers Dement 2022. [DOI: 10.1002/alz.067488] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
| | - Zahra Shirzadi
- Massachusetts General Hospital, Brigham and Women’s Hospital,Harvard Medical School Boston MA USA
| | | | | | | | - Dorene M. Rentz
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| | - Keith A. Johnson
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Reisa A. Sperling
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Jasmeer P. Chhatwal
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| |
Collapse
|
20
|
Weizenbaum EL, Soberanes D, Hsieh S, Schneider OR, Buckley RF, Properzi MJ, Rentz DM, Johnson KA, Sperling RA, Papp KV, Amariglio RE. Using a digital assessment of multi‐day learning curves to detect preclinical AD. Alzheimers Dement 2022. [DOI: 10.1002/alz.062194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Emma L Weizenbaum
- Harvard Medical School Boston MA USA
- Mass General Brigham Boston MA USA
| | | | - Stephanie Hsieh
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | - Rachel F. Buckley
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | - Dorene M. Rentz
- Brigham and Women’s Hospital, Harvard Medical School Boston MA USA
| | - Keith A. Johnson
- Massachusetts General Hospital, Brigham and Women’s Hospital,Harvard Medical School Boston MA USA
| | - Reisa A. Sperling
- Massachusetts General Hospital, Brigham and Women’s Hospital,Harvard Medical School Boston MA USA
| | - Kathryn V. Papp
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | |
Collapse
|
21
|
Yau WYW, Shirzadi Z, Yang HS, Ikoba AP, Rabin JS, Properzi MJ, Kirn DR, Schultz AP, Rentz DM, Johnson KA, Sperling RA, Chhatwal JP. Tau Mediates Synergistic Influence of Vascular Risk and Aβ on Cognitive Decline. Ann Neurol 2022; 92:745-755. [PMID: 35880989 PMCID: PMC9650958 DOI: 10.1002/ana.26460] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2022] [Revised: 07/13/2022] [Accepted: 07/21/2022] [Indexed: 11/08/2022]
Abstract
OBJECTIVE Elevated vascular risk and beta-amyloid (Aβ) burden have been synergistically associated with cognitive decline in preclinical Alzheimer's disease (AD), although the underlying mechanisms remain unclear. We examined whether accelerated longitudinal tau accumulation mediates the vascular risk-Aβ interaction on cognitive decline. METHODS We included 175 cognitively unimpaired older adults (age 70.5 ± 8.0 years). Baseline vascular risk was quantified using the office-based Framingham Heart Study general cardiovascular disease risk score (FHS-CVD). Baseline Aβ burden was measured with Pittsburgh Compound-B positron emission tomography (PET). Tau burden was measured longitudinally (3.6 ± 1.5 years) with Flortaucipir PET, focusing on inferior temporal cortex (ITC). Cognition was assessed longitudinally (7.0 ± 2.0 years) using the Preclinical Alzheimer's Cognitive Composite. Linear mixed effects models examined the interactive effects of baseline vascular risk and Aβ on longitudinal ITC tau. Additionally, moderated mediation was used to determine whether tau accumulation mediated the FHS-CVD*Aβ effect on cognitive decline. RESULTS We observed a significant interaction between elevated baseline FHS-CVD and Aβ on greater ITC tau accumulation (p = 0.004), even in individuals with Aβ burden below the conventional threshold for amyloid positivity. Examining individual vascular risk factors, we found elevated systolic blood pressure and body mass index showed independent interactions with Aβ on longitudinal tau (both p < 0.0001). ITC tau accumulation mediated 33% of the interactive association of FHS-CVD and Aβ on cognitive decline. INTERPRETATION Vascular risks interact with subthreshold levels of Aβ to promote cognitive decline, partially by accelerating early neocortical tau accumulation. Our findings support vascular risk reduction, especially treating hypertension and obesity, to attenuate Aβ-related tau pathology and reduce late-life cognitive decline. ANN NEUROL 2022;92:745-755.
Collapse
Affiliation(s)
- Wai-Ying Wendy Yau
- Department of Neurology, Massachusetts General Hospital, Boston, MA
- Harvard Medical School, Boston, MA
| | - Zahra Shirzadi
- Department of Neurology, Massachusetts General Hospital, Boston, MA
- Harvard Medical School, Boston, MA
| | - Hyun-Sik Yang
- Department of Neurology, Massachusetts General Hospital, Boston, MA
- Harvard Medical School, Boston, MA
- Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, MA
| | - Akpevweoghene P Ikoba
- Department of Neurology, Massachusetts General Hospital, Boston, MA
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, MA
| | - Jennifer S Rabin
- Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
- Harquail Centre for Neuromodulation, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada
- Rehabilitation Sciences Institute, University of Toronto, Toronto, ON, Canada
| | - Michael J Properzi
- Department of Neurology, Massachusetts General Hospital, Boston, MA
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, MA
| | - Dylan R Kirn
- Department of Neurology, Massachusetts General Hospital, Boston, MA
- Harvard Medical School, Boston, MA
| | - Aaron P Schultz
- Department of Neurology, Massachusetts General Hospital, Boston, MA
- Harvard Medical School, Boston, MA
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, MA
| | - Dorene M Rentz
- Department of Neurology, Massachusetts General Hospital, Boston, MA
- Harvard Medical School, Boston, MA
- Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, MA
| | - Keith A Johnson
- Department of Neurology, Massachusetts General Hospital, Boston, MA
- Harvard Medical School, Boston, MA
- Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, MA
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, MA
| | - Reisa A Sperling
- Department of Neurology, Massachusetts General Hospital, Boston, MA
- Harvard Medical School, Boston, MA
- Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, MA
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, MA
| | - Jasmeer P Chhatwal
- Department of Neurology, Massachusetts General Hospital, Boston, MA
- Harvard Medical School, Boston, MA
- Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, MA
| |
Collapse
|
22
|
Eissman JM, Dumitrescu L, Mahoney ER, Smith AN, Mukherjee S, Lee ML, Scollard P, Choi SE, Bush WS, Engelman CD, Lu Q, Fardo DW, Trittschuh EH, Mez J, Kaczorowski CC, Hernandez Saucedo H, Widaman KF, Buckley RF, Properzi MJ, Mormino EC, Yang HS, Harrison TM, Hedden T, Nho K, Andrews SJ, Tommet D, Hadad N, Sanders RE, Ruderfer DM, Gifford KA, Zhong X, Raghavan NS, Vardarajan BN, Pericak-Vance MA, Farrer LA, Wang LS, Cruchaga C, Schellenberg GD, Cox NJ, Haines JL, Keene CD, Saykin AJ, Larson EB, Sperling RA, Mayeux R, Cuccaro ML, Bennett DA, Schneider JA, Crane PK, Jefferson AL, Hohman TJ. Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease. Brain 2022; 145:2541-2554. [PMID: 35552371 PMCID: PMC9337804 DOI: 10.1093/brain/awac177] [Citation(s) in RCA: 23] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2021] [Revised: 04/07/2022] [Accepted: 04/14/2022] [Indexed: 12/04/2022] Open
Abstract
Approximately 30% of elderly adults are cognitively unimpaired at time of death despite the presence of Alzheimer's disease neuropathology at autopsy. Studying individuals who are resilient to the cognitive consequences of Alzheimer's disease neuropathology may uncover novel therapeutic targets to treat Alzheimer's disease. It is well established that there are sex differences in response to Alzheimer's disease pathology, and growing evidence suggests that genetic factors may contribute to these differences. Taken together, we sought to elucidate sex-specific genetic drivers of resilience. We extended our recent large scale genomic analysis of resilience in which we harmonized cognitive data across four cohorts of cognitive ageing, in vivo amyloid PET across two cohorts, and autopsy measures of amyloid neuritic plaque burden across two cohorts. These data were leveraged to build robust, continuous resilience phenotypes. With these phenotypes, we performed sex-stratified [n (males) = 2093, n (females) = 2931] and sex-interaction [n (both sexes) = 5024] genome-wide association studies (GWAS), gene and pathway-based tests, and genetic correlation analyses to clarify the variants, genes and molecular pathways that relate to resilience in a sex-specific manner. Estimated among cognitively normal individuals of both sexes, resilience was 20-25% heritable, and when estimated in either sex among cognitively normal individuals, resilience was 15-44% heritable. In our GWAS, we identified a female-specific locus on chromosome 10 [rs827389, β (females) = 0.08, P (females) = 5.76 × 10-09, β (males) = -0.01, P(males) = 0.70, β (interaction) = 0.09, P (interaction) = 1.01 × 10-04] in which the minor allele was associated with higher resilience scores among females. This locus is located within chromatin loops that interact with promoters of genes involved in RNA processing, including GATA3. Finally, our genetic correlation analyses revealed shared genetic architecture between resilience phenotypes and other complex traits, including a female-specific association with frontotemporal dementia and male-specific associations with heart rate variability traits. We also observed opposing associations between sexes for multiple sclerosis, such that more resilient females had a lower genetic susceptibility to multiple sclerosis, and more resilient males had a higher genetic susceptibility to multiple sclerosis. Overall, we identified sex differences in the genetic architecture of resilience, identified a female-specific resilience locus and highlighted numerous sex-specific molecular pathways that may underly resilience to Alzheimer's disease pathology. This study illustrates the need to conduct sex-aware genomic analyses to identify novel targets that are unidentified in sex-agnostic models. Our findings support the theory that the most successful treatment for an individual with Alzheimer's disease may be personalized based on their biological sex and genetic context.
Collapse
Affiliation(s)
- Jaclyn M Eissman
- Vanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical
Center, Nashville, TN, USA
- Vanderbilt Genetics Institute, Vanderbilt University Medical
Center, Nashville, TN, USA
| | - Logan Dumitrescu
- Vanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical
Center, Nashville, TN, USA
- Vanderbilt Genetics Institute, Vanderbilt University Medical
Center, Nashville, TN, USA
| | - Emily R Mahoney
- Vanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical
Center, Nashville, TN, USA
- Vanderbilt Genetics Institute, Vanderbilt University Medical
Center, Nashville, TN, USA
| | - Alexandra N Smith
- Vanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical
Center, Nashville, TN, USA
- Vanderbilt Genetics Institute, Vanderbilt University Medical
Center, Nashville, TN, USA
| | | | - Michael L Lee
- Department of Medicine, University of Washington,
Seattle, WA, USA
| | - Phoebe Scollard
- Department of Medicine, University of Washington,
Seattle, WA, USA
| | - Seo Eun Choi
- Department of Medicine, University of Washington,
Seattle, WA, USA
| | - William S Bush
- Cleveland Institute for Computational Biology, Department of Population and
Quantitative Health Sciences, Case Western Reserve University,
Cleveland, OH, USA
| | - Corinne D Engelman
- Department of Population Health Sciences, School of Medicine and Public
Health, University of Wisconsin-Madison, Madison,
WI, USA
| | - Qiongshi Lu
- Department of Statistics, University of Wisconsin-Madison,
Madison, WI, USA
- Department of Biostatistics and Medical Informatics, University of
Wisconsin-Madison, Madison, WI, USA
| | - David W Fardo
- Department of Biostatistics, College of Public Health, University of
Kentucky, Lexington, KY, USA
- Sanders-Brown Center on Aging, University of Kentucky,
Lexington, KY, USA
| | - Emily H Trittschuh
- Department of Psychiatry and Behavioral Sciences, University of Washington
School of Medicine, Seattle, WA, USA
- VA Puget Sound Health Care System, GRECC, Seattle,
WA, USA
| | - Jesse Mez
- Department of Neurology, Boston University School of
Medicine, Boston, MA, USA
| | | | - Hector Hernandez Saucedo
- UC Davis Alzheimer's Disease Research Center, Department of Neurology,
University of California Davis Medical Center, Sacramento,
CA, USA
| | | | - Rachel F Buckley
- Department of Neurology, Massachusetts General Hospital/Harvard Medical
School, Boston, MA, USA
- Center for Alzheimer's Research and Treatment, Department of Neurology,
Brigham and Women’s Hospital/Harvard Medical School, Boston,
MA, USA
- Melbourne School of Psychological Sciences, University of
Melbourne, Melbourne, Australia
| | - Michael J Properzi
- Department of Neurology, Massachusetts General Hospital/Harvard Medical
School, Boston, MA, USA
| | - Elizabeth C Mormino
- Department of Neurology and Neurological Sciences, Stanford
University, Stanford, CA, USA
| | - Hyun Sik Yang
- Department of Neurology, Massachusetts General Hospital/Harvard Medical
School, Boston, MA, USA
- Center for Alzheimer's Research and Treatment, Department of Neurology,
Brigham and Women’s Hospital/Harvard Medical School, Boston,
MA, USA
| | - Theresa M Harrison
- Helen Wills Neuroscience Institute, University of California
Berkeley, Berkeley, CA, USA
| | - Trey Hedden
- Icahn School of Medicine at Mount Sinai, New York
City, NY, USA
| | - Kwangsik Nho
- Department of Radiology and Imaging Sciences, Indiana Alzheimer Disease
Center, Indiana University School of Medicine, Indianapolis,
IN, USA
- Center for Computational Biology and Bioinformatics, Indiana University
School of Medicine, Indianapolis, IN, USA
| | - Shea J Andrews
- Icahn School of Medicine at Mount Sinai, New York
City, NY, USA
| | - Douglas Tommet
- Department of Psychiatry and Human Behavior, Brown University School of
Medicine, Providence, RI, USA
| | | | | | - Douglas M Ruderfer
- Vanderbilt Genetics Institute, Vanderbilt University Medical
Center, Nashville, TN, USA
| | - Katherine A Gifford
- Vanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical
Center, Nashville, TN, USA
| | - Xiaoyuan Zhong
- Department of Statistics, University of Wisconsin-Madison,
Madison, WI, USA
- Department of Biostatistics and Medical Informatics, University of
Wisconsin-Madison, Madison, WI, USA
| | - Neha S Raghavan
- Department of Neurology, Columbia University, New
York, NY, USA
- The Taub Institute for Research on Alzheimer's Disease and The Aging Brain,
Columbia University, New York, NY, USA
- The Institute for Genomic Medicine, Columbia University Medical Center and
The New York Presbyterian Hospital, New York, NY,
USA
| | - Badri N Vardarajan
- Department of Neurology, Columbia University, New
York, NY, USA
- The Taub Institute for Research on Alzheimer's Disease and The Aging Brain,
Columbia University, New York, NY, USA
- The Institute for Genomic Medicine, Columbia University Medical Center and
The New York Presbyterian Hospital, New York, NY,
USA
| | | | | | | | - Margaret A Pericak-Vance
- John P. Hussman Institute for Human Genomics, University of Miami School of
Medicine, Miami, FL, USA
| | - Lindsay A Farrer
- Department of Neurology, Boston University School of
Medicine, Boston, MA, USA
- Department of Biostatistics, Boston University School of Public
Health, Boston, MA, USA
- Department of Medicine (Biomedical Genetics), Boston University School of
Medicine, Boston, MA, USA
| | - Li San Wang
- Penn Neurodegeneration Genomics Center, Department of Pathology and
Laboratory Medicine, University of Pennsylvania Perelman School of
Medicine, Philadelphia, PA, USA
| | - Carlos Cruchaga
- Department of Psychiatry, Washington University School of
Medicine, St. Louis, MO, USA
| | - Gerard D Schellenberg
- Penn Neurodegeneration Genomics Center, Department of Pathology and
Laboratory Medicine, University of Pennsylvania Perelman School of
Medicine, Philadelphia, PA, USA
| | - Nancy J Cox
- Vanderbilt Genetics Institute, Vanderbilt University Medical
Center, Nashville, TN, USA
| | - Jonathan L Haines
- Cleveland Institute for Computational Biology, Department of Population and
Quantitative Health Sciences, Case Western Reserve University,
Cleveland, OH, USA
| | - C Dirk Keene
- Department of Pathology, University of Washington,
Seattle, WA, USA
| | - Andrew J Saykin
- Department of Radiology and Imaging Sciences, Indiana University School of
Medicine, Indianapolis, IN, USA
| | - Eric B Larson
- Department of Medicine, University of Washington,
Seattle, WA, USA
- Kaiser Permanente Washington Health Research Institute,
Seattle, WA, USA
| | - Reisa A Sperling
- Department of Neurology, Massachusetts General Hospital/Harvard Medical
School, Boston, MA, USA
| | - Richard Mayeux
- Department of Neurology, Columbia University, New
York, NY, USA
- The Taub Institute for Research on Alzheimer's Disease and The Aging Brain,
Columbia University, New York, NY, USA
- The Institute for Genomic Medicine, Columbia University Medical Center and
The New York Presbyterian Hospital, New York, NY,
USA
| | - Michael L Cuccaro
- John P. Hussman Institute for Human Genomics, University of Miami School of
Medicine, Miami, FL, USA
| | - David A Bennett
- Rush Alzheimer's Disease Center, Rush University Medical
Center, Chicago, IL, USA
| | - Julie A Schneider
- Rush Alzheimer's Disease Center, Rush University Medical
Center, Chicago, IL, USA
| | - Paul K Crane
- Department of Medicine, University of Washington,
Seattle, WA, USA
| | - Angela L Jefferson
- Vanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical
Center, Nashville, TN, USA
| | - Timothy J Hohman
- Vanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical
Center, Nashville, TN, USA
- Vanderbilt Genetics Institute, Vanderbilt University Medical
Center, Nashville, TN, USA
| |
Collapse
|
23
|
Papp KV, Buckley RF, Jacobs HIL, Schultz AP, Properzi MJ, Vannini P, Hanseeuw BJ, Rentz DM, Johnson KA, Sperling RA. Association of Emerging β-Amyloid and Tau Pathology With Early Cognitive Changes in Clinically Normal Older Adults. Neurology 2022; 98:e1512-e1524. [PMID: 35338074 PMCID: PMC9012271 DOI: 10.1212/wnl.0000000000200137] [Citation(s) in RCA: 17] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2021] [Accepted: 01/14/2022] [Indexed: 11/15/2022] Open
Abstract
BACKGROUND AND OBJECTIVES Alzheimer's disease (AD) clinical trials are moving earlier in the disease process, based on emerging signs of beta-amyloid (Aβ) and tau pathology. If early treatment is the right time for intervention, it is critical to find the right test to optimize cognitive outcome measures for clinical trials. We sought to identify cognitive measures associated with the earliest detectable signs of emerging Aβ and tau pathology. METHODS 112 clinically normal adults with longitudinal PIB-PET, FTP-PET and cognitive data for 7+ years were included from the Harvard Aging Brain Study (HABS). Analyses assessed those initially classified as PIB- (<Centiloid (CL) 20), then expanded to include PIB+ individuals up to CL40, the approximate threshold beyond which neocortical tau proliferation begins. Separate linear mixed effects models assessed the effects of emerging global Aβ (PIB slope) and tau (baseline FTP level and FTP slope) in the entorhinal (ERC) and inferior temporal (IT) cortices on multiple cognitive tasks and the Preclinical Alzheimer's Cognitive Composite (PACC) over time. RESULTS Steeper PIB slopes were associated with declining processing speed (DSST, Trails A) in those <CL20 and expanded to include learning/memory retrieval (FCSRT-FR, SRT-tr, LM-immed) in the <CL40 group. FTP had limited effects under CL20, with only rising right IT FTP slope related to declining FCSRT-FR and SRT-tr learning/memory retrieval (FCSRT-FR, SRT-tr). Expanding to include those initially <CL40, rising FTP level and/or slope were related to declines across all tasks, and PIB slope effects on memory retrieval but not DSST were reduced. A composite measure of processing speed and memory retrieval tasks provided the strongest prediction of decline under CL40, while PACC remained optimal at high levels of Aβ (>CL40). DISCUSSION Early, Aβ-mediated cognitive slowing was detected for processing speed measures, while early memory retrieval declines were associated with emerging Aβ and tau pathology. Composites of these measures may help determine whether anti-Aβ or anti-tau therapies administered at the first signs of pathology might preserve cognitive function. CLASSIFICATION OF EVIDENCE This study provides Class I evidence that in clinically normal older adults, emerging PET-detected Alzheimer's disease pathology is associated with declining processing speeds and memory retrieval.
Collapse
Affiliation(s)
- Kathryn V Papp
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.,Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA;3
| | - Rachel F Buckley
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.,Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA;3.,Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Australia
| | - Heidi I L Jacobs
- Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.,Faculty of Health, Medicine and Life Sciences, School for Mental Health and Neuroscience, Alzheimer Centre Limburg, Maastricht University, Maastricht, the Netherlands
| | - Aaron P Schultz
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Michael J Properzi
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Patrizia Vannini
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.,Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA;3
| | - Bernard J Hanseeuw
- Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.,Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
| | - Dorene M Rentz
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.,Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA;3
| | - Keith A Johnson
- Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA;3.,Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Reisa A Sperling
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA .,Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA;3
| |
Collapse
|
24
|
Jutten RJ, Rentz DM, Fu JF, Mayblyum DV, Amariglio RE, Buckley RF, Properzi MJ, Maruff P, Stark CE, Yassa MA, Johnson KA, Sperling RA, Papp KV. Monthly At-Home Computerized Cognitive Testing to Detect Diminished Practice Effects in Preclinical Alzheimer's Disease. Front Aging Neurosci 2022; 13:800126. [PMID: 35095476 PMCID: PMC8792465 DOI: 10.3389/fnagi.2021.800126] [Citation(s) in RCA: 17] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2021] [Accepted: 12/14/2021] [Indexed: 01/12/2023] Open
Abstract
Introduction: We investigated whether monthly assessments of a computerized cognitive composite (C3) could aid in the detection of differences in practice effects (PE) in clinically unimpaired (CU) older adults, and whether diminished PE were associated with Alzheimer's disease (AD) biomarkers and annual cognitive decline. Materials and Methods: N = 114 CU participants (age 77.6 ± 5.0, 61% female, MMSE 29 ± 1.2) from the Harvard Aging Brain Study completed the self-administered C3 monthly, at-home, on an iPad for one year. At baseline, participants underwent in-clinic Preclinical Alzheimer's Cognitive Composite-5 (PACC5) testing, and a subsample (n = 72, age = 77.8 ± 4.9, 59% female, MMSE 29 ± 1.3) had 1-year follow-up in-clinic PACC5 testing available. Participants had undergone PIB-PET imaging (0.99 ± 1.6 years before at-home baseline) and Flortaucipir PET imaging (n = 105, 0.62 ± 1.1 years before at-home baseline). Linear mixed models were used to investigate change over months on the C3 adjusting for age, sex, and years of education, and to extract individual covariate-adjusted slopes over the first 3 months. We investigated the association of 3-month C3 slopes with global amyloid burden and tau deposition in eight predefined regions of interest, and conducted Receiver Operating Characteristic analyses to examine how accurately 3-month C3 slopes could identify individuals that showed >0.10 SD annual decline on the PACC-5. Results: Overall, individuals improved on all C3 measures over 12 months (β = 0.23, 95% CI [0.21-0.25], p < 0.001), but improvement over the first 3 months was greatest (β = 0.68, 95% CI [0.59-0.77], p < 0.001), suggesting stronger PE over initial repeated exposures. However, lower PE over 3 months were associated with more global amyloid burden (r = -0.20, 95% CI [-0.38 - -0.01], p = 0.049) and tau deposition in the entorhinal cortex (r = -0.38, 95% CI [-0.54 - -0.19], p < 0.001) and inferior-temporal lobe (r = -0.23, 95% CI [-0.41 - -0.02], p = 0.03). 3-month C3 slopes exhibited good discriminative ability to identify PACC-5 decliners (AUC 0.91, 95% CI [0.84-0.98]), which was better than baseline C3 (p < 0.001) and baseline PACC-5 scores (p = 0.02). Conclusion: While PE are commonly observed among CU adults, diminished PE over monthly cognitive testing are associated with greater AD biomarker burden and cognitive decline. Our findings imply that unsupervised computerized testing using monthly retest paradigms can provide rapid detection of diminished PE indicative of future cognitive decline in preclinical AD.
Collapse
Affiliation(s)
- Roos J. Jutten
- Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States
| | - Dorene M. Rentz
- Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States
- Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States
| | - Jessie F. Fu
- Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States
| | - Danielle V. Mayblyum
- Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States
| | - Rebecca E. Amariglio
- Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States
- Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States
| | - Rachel F. Buckley
- Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States
- Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, VIC, Australia
| | - Michael J. Properzi
- Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States
| | - Paul Maruff
- CogState Ltd., Melbourne, VIC, Australia
- The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, Australia
| | - Craig E. Stark
- Department of Neurobiology and Behavior, Center for the Neurobiology of Learning and Memory, University of California, Irvine, Irvine, CA, United States
| | - Michael A. Yassa
- Department of Neurobiology and Behavior, Center for the Neurobiology of Learning and Memory, University of California, Irvine, Irvine, CA, United States
| | - Keith A. Johnson
- Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States
- Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States
| | - Reisa A. Sperling
- Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States
- Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States
| | - Kathryn V. Papp
- Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States
- Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States
| |
Collapse
|
25
|
Papp KV, Rentz DM, Buckley RF, Schneider OR, Hsieh S, Soberanes D, Properzi MJ, Schultz AP, Johnson KA, Sperling RA, Amariglio RE. Associations between remote cognitive testing on an individual’s own digital device and amyloid burden on neuroimaging in clinically normal older adults: Results from Boston Remote Assessment for Neurocognitive Health (BRANCH). Alzheimers Dement 2021. [DOI: 10.1002/alz.056209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Kate V. Papp
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| | - Dorene M. Rentz
- Center for Alzheimer’s Research and Treatment, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School Boston MA USA
| | | | | | | | | | | | | | - Keith A. Johnson
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | | |
Collapse
|
26
|
Farrell ME, Papp KV, Buckley RF, Jacobs HI, Schultz AP, Properzi MJ, Vannini P, Hanseeuw B, Rentz DM, Johnson KA, Sperling RA. Sequential early cognitive changes sensitive to rising beta‐amyloid and tau pathology in preclinical AD. Alzheimers Dement 2021. [DOI: 10.1002/alz.056315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
| | - Kate V. Papp
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| | - Rachel F. Buckley
- Massachusetts General Hospital/Harvard Medical School Boston MA USA
- The Florey Institute of Neuroscience and Mental Health Parkville Australia
| | - Heidi I.L. Jacobs
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Maastricht University Maastricht Netherlands
| | - Aaron P Schultz
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | - Patrizia Vannini
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| | - Bernard Hanseeuw
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Institute of Neuroscience, Université Catholique de Louvain Brussels Belgium
| | - Dorene M. Rentz
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| | - Keith A. Johnson
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| | - Reisa A. Sperling
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| |
Collapse
|
27
|
Scott MR, Edwards NC, Properzi MJ, Jacobs HI, Price JC, Manning LK, Mayblyum DV, Rubinstein ZB, Rentz DM, Johnson KA, Sperling RA, Schultz AP, Buckley RF. Extraneous neuroimaging factors do not contribute to sex differences in flortaucipir signal: Analysis of skull binding and partial volume effects. Alzheimers Dement 2021. [DOI: 10.1002/alz.056051] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Matthew R. Scott
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Natalie C Edwards
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | - Heidi I.L. Jacobs
- Maastricht University Maastricht Netherlands
- Department of Radiology, Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Julie C Price
- Department of Radiology, Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
| | - Lyssa K Manning
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | | | - Dorene M. Rentz
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Center for Alzheimer’s Research and Treatment, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School Boston MA USA
| | - Keith A. Johnson
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Center for Alzheimer’s Research and Treatment, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School Boston MA USA
| | - Reisa A. Sperling
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Center for Alzheimer’s Research and Treatment, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School Boston MA USA
| | - Aaron P. Schultz
- Massachusetts General Hospital, Harvard Medical School, Department of Neurology, Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Rachel F. Buckley
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Center for Alzheimer’s Research and Treatment, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School Boston MA USA
- Melbourne School of Psychological Sciences, University of Melbourne Melbourne VIC Australia
| |
Collapse
|
28
|
Hanseeuw B, Jacobs HI, Becker A, Buckley RF, Properzi MJ, Farrell ME, Schultz AP, Sanchez JS, Chhatwal JP, Price JC, Sperling RA, Johnson KA. Longitudinal associations between amyloid and tau‐PET: Impact for prevention trials. Alzheimers Dement 2021. [DOI: 10.1002/alz.056208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Bernard Hanseeuw
- Saint Luc University Hospital, Université Catholique de Louvain Brussels Belgium
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Heidi I.L. Jacobs
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Alex Becker
- Massachusetts General Hospital Boston MA USA
| | | | | | | | - Aaron P. Schultz
- Massachusetts General Hospital, Harvard Medical School, Department of Neurology, Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | - Jasmeer P. Chhatwal
- Massachusetts General Hospital, Athinoula A. Martinos Center for Biomedical Imaging, Harvard Medical School Boston MA USA
| | - Julie C. Price
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
| | - Reisa A. Sperling
- Center for Alzheimer’s Research and Treatment, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School Boston MA USA
| | - Keith A. Johnson
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| |
Collapse
|
29
|
Jutten RJ, Amariglio RE, Properzi MJ, Buckley RF, Maruff PT, Stark CE, Yassa MA, Johnson KA, Sperling RA, Rentz DM, Papp KV. Monthly computerized at‐home assessments to detect cognitive change in preclinical Alzheimer’s disease. Alzheimers Dement 2021. [DOI: 10.1002/alz.056055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Roos J. Jutten
- Massachusetts General Hospital Boston MA USA
- Harvard Medical School Boston MA USA
| | - Rebecca E. Amariglio
- Harvard Medical School Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Michael J Properzi
- Harvard Medical School Boston MA USA
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Rachel F. Buckley
- Harvard Medical School Boston MA USA
- Massachusetts General Hospital/Harvard Medical School Boston MA USA
- Melbourne School of Psychological Sciences, University of Melbourne Melbourne VIC Australia
| | - Paul T Maruff
- Cogstate Ltd. Melbourne VIC Australia
- The Florey Institute of Neuroscience and Mental Health Melbourne VIC Australia
| | | | | | - Keith A. Johnson
- Harvard Medical School Boston MA USA
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Reisa A. Sperling
- Harvard Medical School Boston MA USA
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Brigham and Women's Hospital Boston MA USA
| | - Dorene M. Rentz
- Harvard Medical School Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Kate V. Papp
- Massachusetts General Hospital Boston MA USA
- Harvard Medical School Boston MA USA
- Brigham and Women's Hospital Boston MA USA
| |
Collapse
|
30
|
Rubinstein ZB, Buckley RF, Scott MR, Manning LK, Mayblyum DV, Thibault EG, Jacobs HI, Farrell ME, Properzi MJ, Rabin JS, Chhatwal JP, Lois C, Rentz D, Price JC, Schultz AP, Sperling RA, Johnson KA. Self‐reported history of estrogen hormone therapy differentiates rates of amyloid accumulation (PiB‐PET) relative to males: Findings from the Harvard Aging Brain Study. Alzheimers Dement 2021. [DOI: 10.1002/alz.056069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
| | | | - Matthew R. Scott
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | | | | | | | - Heidi I.L. Jacobs
- Massachusetts General Hospital Boston MA USA
- Maastricht University Maastricht Netherlands
| | | | | | | | | | - Cristina Lois
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | - Dorene Rentz
- Massachusetts General Hospital Boston MA USA
- Brigham and Women's Hospital Boston MA USA
| | | | | | - Reisa A. Sperling
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Brigham and Women's Hospital Boston MA USA
| | - Keith A. Johnson
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Brigham and Women's Hospital Boston MA USA
| |
Collapse
|
31
|
Premnath PY, Gonzalez C, Properzi MJ, Rosenberg PB, Marshall GA, Gatchel JR. Longitudinal associations of regional cortical tau and apathy in mild cognitive impairment and Alzheimer’s disease dementia: Findings from the Alzheimer’s Disease Neuroimaging Initiative. Alzheimers Dement 2021. [DOI: 10.1002/alz.056204] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | - Christopher Gonzalez
- Massachusetts General Hospital Boston MA USA
- Brigham and Women's Hospital Boston MA USA
| | | | | | - Gad A Marshall
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
- Center for Alzheimer Research and Treatment Boston MA USA
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Jennifer R Gatchel
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- McLean Hospital Belmont MA USA
| |
Collapse
|
32
|
Rodriguez‐Vieitez E, Montal V, Sepulcre J, Lois C, Hanseeuw B, Vilaplana E, Schultz AP, Properzi MJ, Scott MR, Amariglio RE, Papp KV, Marshall GA, Fortea J, Johnson KA, Sperling RA, Vannini P. Cortical microstructure is associated with tau burden and predicts cognitive decline and clinical progression in healthy older adults. Alzheimers Dement 2021. [DOI: 10.1002/alz.053011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Elena Rodriguez‐Vieitez
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Karolinska Institutet Stockholm Sweden
| | - Victor Montal
- CIBERNED Network Center for Biomedical Research in Neurodegenerative Diseases National Institute of Health Carlos III Madrid Spain
- Sant Pau Memory Unit Hospital de la Santa Creu i Sant Pau‐Biomedical Research Institute Sant Pau‐Universitat Autònoma de Barcelona Barcelona Spain
| | - Jorge Sepulcre
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Gordon Center for Medical Imaging Boston MA USA
| | - Cristina Lois
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Gordon Center for Medical Imaging Boston MA USA
| | - Bernard Hanseeuw
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Gordon Center for Medical Imaging Boston MA USA
- Saint Luc University Hospital Université Catholique de Louvain Brussels Belgium
| | - Eduard Vilaplana
- CIBERNED Network Center for Biomedical Research in Neurodegenerative Diseases National Institute of Health Carlos III Madrid Spain
- Sant Pau Memory Unit Hospital de la Santa Creu i Sant Pau‐Biomedical Research Institute Sant Pau‐Universitat Autònoma de Barcelona Barcelona Spain
| | - Aaron P. Schultz
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | - Michael J Properzi
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | - Matthew R. Scott
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | - Rebecca E. Amariglio
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Brigham and Women's Hospital Harvard Medical School Boston MA USA
| | - Kate V. Papp
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Brigham and Women's Hospital Harvard Medical School Boston MA USA
| | - Gad A Marshall
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Brigham and Women's Hospital Harvard Medical School Boston MA USA
| | - Juan Fortea
- CIBERNED Network Center for Biomedical Research in Neurodegenerative Diseases National Institute of Health Carlos III Madrid Spain
- Sant Pau Memory Unit Hospital de la Santa Creu i Sant Pau‐Biomedical Research Institute Sant Pau‐Universitat Autònoma de Barcelona Barcelona Spain
| | - Keith A. Johnson
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Gordon Center for Medical Imaging Boston MA USA
| | - Reisa A. Sperling
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Brigham and Women's Hospital Harvard Medical School Boston MA USA
| | - Patrizia Vannini
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Brigham and Women's Hospital Harvard Medical School Boston MA USA
| |
Collapse
|
33
|
Gonzalez C, Premnath PY, Kuppe MK, Fitzpatrick CD, Properzi MJ, Becker A, Johnson KA, Rentz DM, Gatchel JR, Vannini P, Amariglio RE, Marshall GA. Association between the Harvard automated phone task and Alzheimer’s disease pathology in clinically normal older adults. Alzheimers Dement 2021. [DOI: 10.1002/alz.052879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- Christopher Gonzalez
- Massachusetts General Hospital Boston MA USA
- Brigham and Women's Hospital Boston MA USA
| | | | | | | | | | - Alex Becker
- Massachusetts General Hospital Boston MA USA
| | - Keith A. Johnson
- Brigham and Women's Hospital Boston MA USA
- Center for Alzheimer’s Research and Treatment Department of Neurology Brigham and Women’s Hospital Harvard Medical School Boston MA USA
- Department of Neurology Massachusetts General Hospital Boston MA USA
| | - Dorene M. Rentz
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Center for Alzheimer’s Research and Treatment Department of Neurology Brigham and Women’s Hospital Harvard Medical School Boston MA USA
- Brigham and Women's Hospital Harvard Medical School Boston MA USA
| | | | - Patrizia Vannini
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Brigham and Women's Hospital Harvard Medical School Boston MA USA
- Center for Alzheimer Research and Treatment Brigham and Women's Hospital Boston MA USA
| | - Rebecca E. Amariglio
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Brigham and Women's Hospital Harvard Medical School Boston MA USA
- Center for Alzheimer Research and Treatment Brigham and Women's Hospital Boston MA USA
| | - Gad A. Marshall
- Massachusetts General Hospital Boston MA USA
- Brigham and Women's Hospital Boston MA USA
- Center for Alzheimer Research and Treatment Brigham and Women's Hospital Boston MA USA
| |
Collapse
|
34
|
Jacobs HI, Becker A, Kwong K, Engels N, Prokopiou PC, Papp KV, Properzi MJ, Hampton OL, Sanchez JS, Rentz DM, Fakhri GE, Normandin MD, Bennett DA, Sperling RA, Johnson KA. Locus coeruleus integrity as a proxy of initial tau burden: in vivo versus ex vivo observations. Alzheimers Dement 2021. [DOI: 10.1002/alz.056391] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- Heidi I.L. Jacobs
- Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University Maastricht Netherlands
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Gordon Center for Medical Imaging, Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Faculty of Health, Medicine and Life Sciences, Maastricht University Maastricht Netherlands
| | - Alex Becker
- Massachusetts General Hospital Boston MA USA
| | - Kenneth Kwong
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Nina Engels
- Gordon Center for Medical Imaging, Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Massachusetts General Hospital Charlestown MA USA
| | | | - Kate V. Papp
- Massachusetts General Hospital Boston MA USA
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| | | | - Olivia L. Hampton
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | - Dorene M. Rentz
- Center for Alzheimer’s Research and Treatment, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School Boston MA USA
| | | | | | - David A. Bennett
- Rush Alzheimer’s Disease Center and Department of Neurological Sciences, Rush University Medical Center Chicago IL USA
| | - Reisa A. Sperling
- Center for Alzheimer’s Research and Treatment, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School Boston MA USA
| | - Keith A. Johnson
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
- Gordon Center for Medical Imaging Boston MA USA
| |
Collapse
|
35
|
Tommasi NS, Gonzalez C, Briggs D, Properzi MJ, Gatchel JR, Marshall GA. Affective symptoms and regional cerebral tau burden in early-stage Alzheimer's disease. Int J Geriatr Psychiatry 2021; 36:1050-1058. [PMID: 33682933 PMCID: PMC8187284 DOI: 10.1002/gps.5530] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/16/2021] [Accepted: 02/26/2021] [Indexed: 12/12/2022]
Abstract
OBJECTIVE Neuropsychiatric symptoms (NPS) are often present in individuals with mild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia. NPS are associated with structural and functional changes in the brain such as atrophy, regional hypometabolism, and hypoperfusion, considered proxies of neurodegeneration. Our objective was to evaluate the association between NPS and regional cerebral tau burden, a more direct representation of neurodegeneration, in cognitively normal (CN), MCI, and AD dementia individuals. METHODS Cross-sectional NPS were assessed using the Neuropsychiatric Inventory (NPI) in 410 CN, 199 MCI, and 61 AD dementia participants who underwent flortaucipir tau positron emission tomography as part of the AD Neuroimaging Initiative (ADNI). Total NPI score and two factors of NPS (affective and hyperactive) were used in analyses. Linear regression models with backward elimination were employed with NPI as dependent variable and regional tau or tau-amyloid interaction as predictor of interest. Covariates included education, age, sex, Rey Auditory Verbal Learning Test Total Learning, and Trail Making Test B. RESULTS There were significant associations (p < 0.05) between the NPI variables (total score, Affective factor) and entorhinal and precuneus tau across all participants. These associations were also significant for the tau-amyloid interaction. These effects were significant in cognitively symptomatic participants (MCI and AD dementia), but not in CN participants. CONCLUSIONS Increased tau burden in the entorhinal and precuneus cortices was modestly associated with greater NPS in MCI and AD dementia. Further evaluation of NPS and their effect on early-stage AD could aid in finding new interventions and slowing disease progression.
Collapse
Affiliation(s)
- Nicole S. Tommasi
- Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 02115, USA;,Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 02115, USA
| | - Christopher Gonzalez
- Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 02115, USA;,Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 02115, USA;,Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
| | - Danielle Briggs
- Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 02115, USA;,Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 02115, USA;,Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
| | - Michael J. Properzi
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
| | - Jennifer R. Gatchel
- Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA;,Division of Geriatric Psychiatry, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA
| | - Gad A. Marshall
- Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 02115, USA;,Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 02115, USA;,Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA;,Correspondence to: Gad A. Marshall, MD, Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, 60 Fenwood Road, 9016P, Boston, MA 02115, P: 617-732-8085, F: 617-264-6831,
| | | |
Collapse
|
36
|
Sanchez JS, Becker JA, Jacobs HIL, Hanseeuw BJ, Jiang S, Schultz AP, Properzi MJ, Katz SR, Beiser A, Satizabal CL, O'Donnell A, DeCarli C, Killiany R, El Fakhri G, Normandin MD, Gómez-Isla T, Quiroz YT, Rentz DM, Sperling RA, Seshadri S, Augustinack J, Price JC, Johnson KA. The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomography. Sci Transl Med 2021; 13:eabc0655. [PMID: 33472953 PMCID: PMC7978042 DOI: 10.1126/scitranslmed.abc0655] [Citation(s) in RCA: 81] [Impact Index Per Article: 27.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2020] [Accepted: 09/10/2020] [Indexed: 12/15/2022]
Abstract
Advances in molecular positron emission tomography (PET) have enabled anatomic tracking of brain pathology in longitudinal studies of normal aging and dementia, including assessment of the central model of Alzheimer's disease (AD) pathogenesis, according to which TAU pathology begins focally but expands catastrophically under the influence of amyloid-β (Aβ) pathology to mediate neurodegeneration and cognitive decline. Initial TAU deposition occurs many years before Aβ in a specific area of the medial temporal lobe. Building on recent work that enabled focus of molecular PET measurements on specific TAU-vulnerable convolutional temporal lobe anatomy, we applied an automated anatomic sampling method to quantify TAU PET signal in 443 adult participants from several observational studies of aging and AD, spanning a wide range of ages, Aβ burdens, and degrees of clinical impairment. We detected initial cortical emergence of tauopathy near the rhinal sulcus in clinically normal people and, in a subset with longitudinal 2-year follow-up data (n = 104), tracked Aβ-associated spread of TAU from this site first to nearby neocortex of the temporal lobe and then to extratemporal regions. Greater rate of TAU spread was associated with baseline measures of both global Aβ burden and medial temporal lobe TAU. These findings are consistent with clinicopathological correlation studies of Alzheimer's tauopathy and enable precise tracking of AD-related TAU progression for natural history studies and prevention therapeutic trials.
Collapse
Affiliation(s)
- Justin S Sanchez
- Massachusetts General Hospital, Boston, MA 02114, USA.
- Harvard Medical School, Boston, MA 02115, USA
- Gordon Center for Medical Imaging, Boston, MA, 02114, USA
| | - J Alex Becker
- Massachusetts General Hospital, Boston, MA 02114, USA
- Harvard Medical School, Boston, MA 02115, USA
- Gordon Center for Medical Imaging, Boston, MA, 02114, USA
| | - Heidi I L Jacobs
- Massachusetts General Hospital, Boston, MA 02114, USA
- Harvard Medical School, Boston, MA 02115, USA
- Gordon Center for Medical Imaging, Boston, MA, 02114, USA
- School for Mental Health and Neuroscience, Alzheimer Centre Limburg, Maastricht University, Maastricht, 6211 LK, Netherlands
| | - Bernard J Hanseeuw
- Massachusetts General Hospital, Boston, MA 02114, USA
- Harvard Medical School, Boston, MA 02115, USA
- Gordon Center for Medical Imaging, Boston, MA, 02114, USA
- Université Catholique de Louvain, Brussels B-1348, Belgium
| | - Shu Jiang
- Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
- Washington University School of Medicine, St. Louis, MO 63110, USA
| | - Aaron P Schultz
- Massachusetts General Hospital, Boston, MA 02114, USA
- Harvard Medical School, Boston, MA 02115, USA
| | - Michael J Properzi
- Massachusetts General Hospital, Boston, MA 02114, USA
- Harvard Medical School, Boston, MA 02115, USA
| | - Samantha R Katz
- Massachusetts General Hospital, Boston, MA 02114, USA
- Harvard Medical School, Boston, MA 02115, USA
- Gordon Center for Medical Imaging, Boston, MA, 02114, USA
| | - Alexa Beiser
- Boston University School of Medicine, Boston, MA 02118, USA
- Boston University School of Public Health, Boston, MA 02118, USA
- Framingham Heart Study, Framingham, MA 01702, USA
| | - Claudia L Satizabal
- Boston University School of Medicine, Boston, MA 02118, USA
- Framingham Heart Study, Framingham, MA 01702, USA
- Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Sciences Center, San Antonio, TX 78229, USA
| | - Adrienne O'Donnell
- Boston University School of Public Health, Boston, MA 02118, USA
- Framingham Heart Study, Framingham, MA 01702, USA
| | | | - Ron Killiany
- Boston University School of Medicine, Boston, MA 02118, USA
- Boston University School of Public Health, Boston, MA 02118, USA
| | - Georges El Fakhri
- Massachusetts General Hospital, Boston, MA 02114, USA
- Harvard Medical School, Boston, MA 02115, USA
- Gordon Center for Medical Imaging, Boston, MA, 02114, USA
| | - Marc D Normandin
- Massachusetts General Hospital, Boston, MA 02114, USA
- Harvard Medical School, Boston, MA 02115, USA
- Gordon Center for Medical Imaging, Boston, MA, 02114, USA
| | - Teresa Gómez-Isla
- Massachusetts General Hospital, Boston, MA 02114, USA
- Harvard Medical School, Boston, MA 02115, USA
| | - Yakeel T Quiroz
- Massachusetts General Hospital, Boston, MA 02114, USA
- Harvard Medical School, Boston, MA 02115, USA
- Grupo de Neurociencias, Universidad de Antioquia, Antioquia 050010, Colombia
| | - Dorene M Rentz
- Massachusetts General Hospital, Boston, MA 02114, USA
- Harvard Medical School, Boston, MA 02115, USA
- Brigham and Women's Hospital, Boston, MA 02115, USA
| | - Reisa A Sperling
- Massachusetts General Hospital, Boston, MA 02114, USA
- Harvard Medical School, Boston, MA 02115, USA
- Brigham and Women's Hospital, Boston, MA 02115, USA
| | - Sudha Seshadri
- Boston University School of Medicine, Boston, MA 02118, USA
- Framingham Heart Study, Framingham, MA 01702, USA
- Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Sciences Center, San Antonio, TX 78229, USA
| | - Jean Augustinack
- Massachusetts General Hospital, Boston, MA 02114, USA
- Harvard Medical School, Boston, MA 02115, USA
| | - Julie C Price
- Massachusetts General Hospital, Boston, MA 02114, USA
- Harvard Medical School, Boston, MA 02115, USA
| | - Keith A Johnson
- Massachusetts General Hospital, Boston, MA 02114, USA.
- Harvard Medical School, Boston, MA 02115, USA
- Gordon Center for Medical Imaging, Boston, MA, 02114, USA
- Brigham and Women's Hospital, Boston, MA 02115, USA
| |
Collapse
|
37
|
Gonzalez C, Tommasi NS, Briggs D, Properzi MJ, Amariglio RE, Marshall GA. Financial Capacity and Regional Cerebral Tau in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Dementia. J Alzheimers Dis 2021; 79:1133-1142. [PMID: 33386806 DOI: 10.3233/jad-201122] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
BACKGROUND Financial capacity is often one of the first instrumental activities of daily living to be affected in cognitively normal (CN) older adults who later progress to amnestic mild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia. OBJECTIVE The objective of this study was to investigate the association between financial capacity and regional cerebral tau. METHODS Cross-sectional financial capacity was assessed using the Financial Capacity Instrument -Short Form (FCI-SF) in 410 CN, 199 MCI, and 61 AD dementia participants who underwent flortaucipir tau positron emission tomography from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Linear regression models with backward elimination were used with FCI-SF total score as the dependent variable and regional tau and tau-amyloid interaction as predictors of interest in separate analyses. Education, age, sex, Rey Auditory Verbal Learning Test Total Learning, and Trail Making Test B were used as covariates. RESULTS Significant associations were found between FCI-SF and tau regions (entorhinal: p < 0.001; inferior temporal: p < 0.001; dorsolateral prefrontal: p = 0.01; posterior cingulate: p = 0.03; precuneus: p < 0.001; and supramarginal gyrus: p = 0.005) across all participants. For the tau-amyloid interaction, significant associations were found in four regions (amyloid and dorsolateral prefrontal tau interaction: p = 0.005; amyloid and posterior cingulate tau interaction: p = 0.005; amyloid and precuneus tau interaction: p < 0.001; and amyloid and supramarginal tau interaction: p = 0.002). CONCLUSION Greater regional tau burden was modestly associated with financial capacity impairment in early-stage AD. Extending this work with longitudinal analyses will further illustrate the utility of such assessments in detecting clinically meaningful decline, which may aid clinical trials of early-stage AD.
Collapse
Affiliation(s)
- Christopher Gonzalez
- Center for Alzheimer Research and Treatment, Boston, MA, USA.,Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.,Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Nicole S Tommasi
- Center for Alzheimer Research and Treatment, Boston, MA, USA.,Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Danielle Briggs
- Center for Alzheimer Research and Treatment, Boston, MA, USA.,Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.,Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Michael J Properzi
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Rebecca E Amariglio
- Center for Alzheimer Research and Treatment, Boston, MA, USA.,Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.,Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Gad A Marshall
- Center for Alzheimer Research and Treatment, Boston, MA, USA.,Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.,Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | | |
Collapse
|
38
|
Rodriguez-Vieitez E, Montal V, Sepulcre J, Lois C, Hanseeuw B, Vilaplana E, Schultz AP, Properzi MJ, Scott MR, Amariglio R, Papp KV, Marshall GA, Fortea J, Johnson KA, Sperling RA, Vannini P. Association of cortical microstructure with amyloid-β and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults. Mol Psychiatry 2021; 26:7813-7822. [PMID: 34588623 PMCID: PMC8873001 DOI: 10.1038/s41380-021-01290-z] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/12/2021] [Revised: 08/16/2021] [Accepted: 09/03/2021] [Indexed: 02/07/2023]
Abstract
Noninvasive biomarkers of early neuronal injury may help identify cognitively normal individuals at risk of developing Alzheimer's disease (AD). A recent diffusion-weighted imaging (DWI) method allows assessing cortical microstructure via cortical mean diffusivity (cMD), suggested to be more sensitive than macrostructural neurodegeneration. Here, we aimed to investigate the association of cMD with amyloid-β and tau pathology in older adults, and whether cMD predicts longitudinal cognitive decline, neurodegeneration and clinical progression. The study sample comprised n = 196 cognitively normal older adults (mean[SD] 72.5 [9.4] years; 114 women [58.2%]) from the Harvard Aging Brain Study. At baseline, all participants underwent structural MRI, DWI, 11C-Pittsburgh compound-B-PET, 18F-flortaucipir-PET imaging, and cognitive assessments. Longitudinal measures of Preclinical Alzheimer Cognitive Composite-5 were available for n = 186 individuals over 3.72 (1.96)-year follow-up. Prospective clinical follow-up was available for n = 163 individuals over 3.2 (1.7) years. Surface-based image analysis assessed vertex-wise relationships between cMD, global amyloid-β, and entorhinal and inferior-temporal tau. Multivariable regression, mixed effects models and Cox proportional hazards regression assessed longitudinal cognition, brain structural changes and clinical progression. Tau, but not amyloid-β, was positively associated with cMD in AD-vulnerable regions. Correcting for baseline demographics and cognition, increased cMD predicted steeper cognitive decline, which remained significant after correcting for amyloid-β, thickness, and entorhinal tau; there was a synergistic interaction between cMD and both amyloid-β and tau on cognitive slope. Regional cMD predicted hippocampal atrophy rate, independently from amyloid-β, tau, and thickness. Elevated cMD predicted progression to mild cognitive impairment. Cortical microstructure is a noninvasive biomarker that independently predicts subsequent cognitive decline, neurodegeneration and clinical progression, suggesting utility in clinical trials.
Collapse
Affiliation(s)
- Elena Rodriguez-Vieitez
- grid.38142.3c000000041936754XMassachusetts General Hospital, Harvard Medical School, Boston, MA USA ,grid.509504.d0000 0004 0475 2664Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA USA ,grid.4714.60000 0004 1937 0626Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
| | - Victor Montal
- grid.7080.f0000 0001 2296 0625Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain ,grid.418264.d0000 0004 1762 4012Centre of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain
| | - Jorge Sepulcre
- grid.38142.3c000000041936754XMassachusetts General Hospital, Harvard Medical School, Boston, MA USA ,grid.512020.4Gordon Center for Medical Imaging, Boston, MA USA
| | - Cristina Lois
- grid.38142.3c000000041936754XMassachusetts General Hospital, Harvard Medical School, Boston, MA USA ,grid.512020.4Gordon Center for Medical Imaging, Boston, MA USA
| | - Bernard Hanseeuw
- grid.38142.3c000000041936754XMassachusetts General Hospital, Harvard Medical School, Boston, MA USA ,grid.512020.4Gordon Center for Medical Imaging, Boston, MA USA ,grid.7942.80000 0001 2294 713XSaint Luc University Hospital, Université Catholique de Louvain, Brussels, Belgium
| | - Eduard Vilaplana
- grid.7080.f0000 0001 2296 0625Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain ,grid.418264.d0000 0004 1762 4012Centre of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain
| | - Aaron P. Schultz
- grid.38142.3c000000041936754XMassachusetts General Hospital, Harvard Medical School, Boston, MA USA ,grid.509504.d0000 0004 0475 2664Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA USA
| | - Michael J. Properzi
- grid.38142.3c000000041936754XMassachusetts General Hospital, Harvard Medical School, Boston, MA USA
| | - Matthew R. Scott
- grid.38142.3c000000041936754XMassachusetts General Hospital, Harvard Medical School, Boston, MA USA ,grid.509504.d0000 0004 0475 2664Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA USA
| | - Rebecca Amariglio
- grid.38142.3c000000041936754XMassachusetts General Hospital, Harvard Medical School, Boston, MA USA ,grid.38142.3c000000041936754XBrigham and Women’s Hospital, Harvard Medical School, Boston, MA USA
| | - Kathryn V. Papp
- grid.38142.3c000000041936754XMassachusetts General Hospital, Harvard Medical School, Boston, MA USA ,grid.509504.d0000 0004 0475 2664Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA USA ,grid.38142.3c000000041936754XBrigham and Women’s Hospital, Harvard Medical School, Boston, MA USA
| | - Gad A. Marshall
- grid.38142.3c000000041936754XMassachusetts General Hospital, Harvard Medical School, Boston, MA USA ,grid.509504.d0000 0004 0475 2664Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA USA ,grid.38142.3c000000041936754XBrigham and Women’s Hospital, Harvard Medical School, Boston, MA USA
| | - Juan Fortea
- grid.7080.f0000 0001 2296 0625Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain ,grid.418264.d0000 0004 1762 4012Centre of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain
| | - Keith A. Johnson
- grid.38142.3c000000041936754XMassachusetts General Hospital, Harvard Medical School, Boston, MA USA ,grid.512020.4Gordon Center for Medical Imaging, Boston, MA USA
| | - Reisa A. Sperling
- grid.38142.3c000000041936754XMassachusetts General Hospital, Harvard Medical School, Boston, MA USA ,grid.509504.d0000 0004 0475 2664Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA USA ,grid.38142.3c000000041936754XBrigham and Women’s Hospital, Harvard Medical School, Boston, MA USA
| | - Patrizia Vannini
- Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. .,Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, USA. .,Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
| |
Collapse
|
39
|
Dubbelman MA, Jutten RJ, Farias ST, Amariglio R, Buckley RF, Visser PJ, Rentz DM, Johnson KA, Properzi MJ, Schultz AP, Donovan N, Gatchel JR, Teunissen CE, Van Berckel BN, van Der Flier W, Sperling RA, Papp KV, Scheltens P, Marshall GA, Sikkes SA. Trajectories of decline in cognitively complex everyday activities across the Alzheimer’s disease continuum. Alzheimers Dement 2020. [DOI: 10.1002/alz.044787] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Mark A. Dubbelman
- Alzheimer Center Amsterdam, Department of Neurology Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam University Medical Center Amsterdam Netherlands
| | - Roos J. Jutten
- Alzheimer Center Amsterdam, Department of Neurology Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam Amsterdam Netherlands
| | | | | | - Rachel F. Buckley
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | - Dorene M. Rentz
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Keith A. Johnson
- Division of Nuclear Medicine and Molecular Imaging, Department of Radiology Massachusetts General Hospital/Harvard Medical School Boston MA USA
| | | | - Aaron P. Schultz
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Nancy Donovan
- Department of Neurology Brigham and Women’s Hospital, Harvard Medical School Boston, MA, United States Boston MA USA
| | | | - Charlotte E. Teunissen
- Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | | | | | | | - Kathryn V. Papp
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| | - Philip Scheltens
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam Netherlands
| | - Gad A. Marshall
- Center for Alzheimer Research and Treatment Brigham and Women's Hospital Boston MA USA
| | | |
Collapse
|
40
|
Buckley RF, Properzi MJ, Schultz AP, Scott MR, Jacobs HI, Farrell ME, Kirn D, Hanseeuw BJ, Amariglio R, Rentz D, Johnson KA, Sperling RA. Faster rates of tau accumulation in FTP‐PET in females relative to males, and a cross‐sectional influence on faster cognitive decline: Preliminary findings from HABS and ADNI. Alzheimers Dement 2020. [DOI: 10.1002/alz.043620] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- Rachel F. Buckley
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Harvard Medical School Boston MA USA
- Massachusetts General Hospital Boston MA USA
- University of Melbourne Melbourne Australia
| | | | - Aaron P. Schultz
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | - Matthew R. Scott
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | - Heidi I.L. Jacobs
- Division of Nuclear Medicine anCMolecular Imaging, Department of Radiology Massachusetts General Hospital/Harvard Medical School Boston MA USA
| | - Michelle E. Farrell
- Athinoula A. Martinos Center for Biomedical Imaging Massachusetts General Hospital, Harvard Medical School Charlestown MA USA
| | - Dylan Kirn
- Massachusetts General Hospital Boston MA USA
| | - Bernard J. Hanseeuw
- Gordon Center for Medical Imaging Massachusetts General Hospital Harvard Medical School Boston MA USA
| | | | | | - Keith A. Johnson
- Division of Nuclear Medicine anCMolecular Imaging, Department of Radiology Massachusetts General Hospital/Harvard Medical School Boston MA USA
| | | |
Collapse
|
41
|
Gatchel JR, Marshall GA, Locascio JJ, Yang H, Donovan NJ, Buckley RF, Properzi MJ, Quiroz YT, Rabin JS, Vannini P, Amariglio R, Chhatwal JP, Rentz DM, Blacker D, Sperling RA, Johnson KA, Hanseeuw B. Association of tau tangle burden with depressive symptoms in community‐dwelling older adults: A longitudinal study. Alzheimers Dement 2020. [DOI: 10.1002/alz.046549] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
| | - Gad A Marshall
- Center for Alzheimer Research and Treatment Brigham and Women's Hospital Boston MA USA
| | | | | | | | - Rachel F Buckley
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | | | | | - Jennifer S Rabin
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | - Patrizia Vannini
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | | | - Jasmeer P Chhatwal
- Massachusetts General Hospital, Athinoula A. Martinos Center for Biomedical Imaging Harvard Medical School Boston MA USA
| | - Dorene M Rentz
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | - Deborah Blacker
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | - Reisa A Sperling
- Brigham and Women's Hospital Harvard Medical School Boston MA USA
| | - Keith A Johnson
- Division of Nuclear Medicine and Molecular Imaging Department of Radiology Massachusetts General Hospital/Harvard Medical School Boston MA USA
| | - Bernard Hanseeuw
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| |
Collapse
|
42
|
Muniz MC, Martínez J, Vila‐Castelar C, Pardilla‐Delgado E, Scott MR, Properzi MJ, Kirn D, Rentz D, Sperling RA, Quiroz YT, Pruzin JJ, Ramirez‐Gomez LA. Evaluating pre‐screening tools for older Latino recruitment into preclinical Alzheimer’s disease studies. Alzheimers Dement 2020. [DOI: 10.1002/alz.041571] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- Martha C. Muniz
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | | | | | | | - Matthew R. Scott
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
| | | | - Dylan Kirn
- Massachusetts General Hospital Boston MA USA
| | | | | | | | | | | |
Collapse
|
43
|
Dumitrescu L, Mahoney ER, Mukherjee S, Lee ML, Bush WS, Engelman CD, Lu Q, Fardo DW, Trittschuh EH, Mez J, Kaczorowski CC, Widaman KF, Buckley RF, Properzi MJ, Mormino EC, Yang H, Andrews SJ, Sanders RE, Raghavan NS, Vardarajan BN, Schellenberg GD, Cruchaga C, Haines JL, Keene CD, Saykin AJ, Larson EB, Sperling RA, Mayeux R, Bennett DA, Schneider JA, Crane PK, Jefferson AL, Hohman TJ. Sex differences in genetic predictors of resilience to Alzheimer’s disease. Alzheimers Dement 2020. [DOI: 10.1002/alz.043259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
| | | | | | | | - William S. Bush
- Department of Population and Quantitative Health Sciences Case Western Reserve University Cleveland OH USA
| | - Corinne D. Engelman
- Wisconsin Alzheimer’s Disease Research Center University of Wisconsin School of Medicine and Public Health Madison WI USA
| | - Qiongshi Lu
- Department of Biostatistics & Medical Informatics University of Wisconsin School of Medicine and Public Health Madison WI USA
| | | | | | - Jesse Mez
- Boston University Alzheimer’s Disease Center Boston MA USA
| | | | | | - Rachel F. Buckley
- Athinoula A. Martinos Center for Biomedical Imaging Massachusetts General Hospital Harvard Medical School Charlestown MA USA
| | | | | | | | | | | | | | | | | | - Carlos Cruchaga
- Washington University in St. Louis School of Medicine St. Louis MO USA
| | | | | | | | - Eric B. Larson
- Kaiser Permanente Washington Health Research Institute Seattle WA USA
| | | | | | - David A. Bennett
- Rush Alzheimer’s Disease Center Rush University Medical Center Chicago IL USA
| | - Julie A. Schneider
- Rush Alzheimer’s Disease Center Rush University Medical Center Chicago IL USA
| | | | | | | | | |
Collapse
|
44
|
Gatchel JR, Marshall GA, Locascio JJ, Yang H, Donovan NJ, Buckley RF, Properzi MJ, Quiroz YT, Rabin JS, Vannini P, Amariglio R, Chhatwal JP, Rentz D, Blacker D, Sperling RA, Johnson KA, Hanseeuw BJ. Association of tau tangle burden with depressive symptoms in community‐dwelling older adults: A longitudinal study. Alzheimers Dement 2020. [DOI: 10.1002/alz.038867] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | - Gad A. Marshall
- Center for Alzheimer Research and Treatment Brigham and Women's Hospital Boston MA USA
| | | | | | | | | | | | | | | | - Patrizia Vannini
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | | | | | | | - Deborah Blacker
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | | | - Keith A. Johnson
- Division of Nuclear Medicine and Molecular Imaging, Department of Radiology Massachusetts General Hospital/Harvard Medical School Boston MA USA
| | - Bernard J Hanseeuw
- Gordon Center for Medical Imaging Massachusetts General Hospital, Harvard Medical School Boston MA USA
| |
Collapse
|
45
|
Hanseeuw B, Jacobs HI, Schultz AP, Buckley RF, Properzi MJ, Becker A, Farrell ME, Scott MR, Hampton OL, Sanchez JS, Quiroz YT, Chhatwal JP, Price JC, Sperling RA, Johnson KA. Longitudinal hippocampal atrophy is associated with an amyloid‐independent entorhinal tauopathy and an amyloid‐dependent neocortical tauopathy. Alzheimers Dement 2020. [DOI: 10.1002/alz.045733] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- Bernard Hanseeuw
- Saint Luc University Hospital Université Catholique de Louvain Brussels Belgium
- Gordon Center for Medical Imaging Radiology Department Massachusetts General Hospital Boston MA USA
| | | | - Aaron P. Schultz
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | | | | | - Alex Becker
- Massachusetts General Hospital Boston MA USA
| | - Michelle E. Farrell
- Athinoula A. Martinos Center for Biomedical Imaging Massachusetts General Hospital Harvard Medical School Charlestown MA USA
| | - Matthew R. Scott
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | | | | | | | - Jasmeer P. Chhatwal
- Massachusetts General Hospital Athinoula A. Martinos Center for Biomedical Imaging Harvard Medical School Boston MA USA
| | | | | | - Keith A. Johnson
- Division of Nuclear Medicine and Molecular Imaging Department of Radiology Massachusetts General Hospital/Harvard Medical School Boston MA USA
| |
Collapse
|
46
|
Hampton OL, Buckley RF, Properzi MJ, Chhatwal JP, Johnson KA, Sperling RA, Schultz AP. Longitudinal inferior temporal FTP‐PET signal increase is associated with contemporaneous longitudinal temporal lobe cortical thinning in preclinical Alzheimer’s disease. Alzheimers Dement 2020. [DOI: 10.1002/alz.043419] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
| | - Rachel F. Buckley
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital Harvard Medical School Charlestown MA USA
| | | | | | - Keith A. Johnson
- Gordon Center for Medical Imaging, Massachusetts General Hospital Harvard Medical School Boston MA USA
| | | | - Aaron P. Schultz
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| |
Collapse
|
47
|
Properzi MJ, Buckley RF, Papp KV, Farrell ME, Jacobs HI, Hanseeuw BJ, Rabin JS, Chhatwal JP, Rentz DM, Johnson KA, Sperling RA, Schultz AP. Estimating an individual's placement on a theoretical continuum using longitudinal cognitive trajectories: Relationships with longitudinal amyloid and Tau‐PET. Alzheimers Dement 2020. [DOI: 10.1002/alz.043566] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
| | - Rachel F. Buckley
- Athinoula A. Martinos Center for Biomedical Imaging Massachusetts General Hospital, Harvard Medical School Charlestown MA USA
| | - Kathryn V. Papp
- Brigham and Women's Hospital, Harvard Medical School Boston MA USA
| | - Michelle E. Farrell
- Athinoula A. Martinos Center for Biomedical Imaging Massachusetts General Hospital, Harvard Medical School Charlestown MA USA
| | - Heidi I.L. Jacobs
- Division of Nuclear Medicine and Molecular Imaging, Department of Radiology Massachusetts General Hospital/Harvard Medical School Boston MA USA
| | | | - Jennifer S. Rabin
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | - Dorene M. Rentz
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | - Keith A. Johnson
- Gordon Center for Medical Imaging Massachusetts General Hospital, Harvard Medical School Boston MA USA
| | | | - Aaron P. Schultz
- Massachusetts General Hospital, Harvard Medical School Boston MA USA
| |
Collapse
|
48
|
Premnath P, Marshall GA, Buckley RF, Donovan N, Jacobs HI, Amariglio R, Vannini P, Chou HL, Properzi MJ, Quiroz YT, Rentz DM, Johnson KA, Sperling RA, Hanseeuw B, Gatchel JR. Longitudinal increase in depressive symptoms in relation to neurodegeneration in clinically normal older adults: Findings from the Harvard Aging Brain Study. Alzheimers Dement 2020. [DOI: 10.1002/alz.047321] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
| | - Gad A. Marshall
- Center for Alzheimer Research and Treatment Brigham and Women's Hospital Boston MA USA
| | | | - Nancy Donovan
- Department of Neurology, Brigham and Women’s Hospital Harvard Medical School Boston MA USA
| | | | | | - Patrizia Vannini
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | | | | | | | - Dorene M. Rentz
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | - Keith A. Johnson
- Division of Nuclear Medicine and Molecular Imaging, Department of Radiology Massachusetts General Hospital/Harvard Medical School Boston MA USA
| | | | - Bernard Hanseeuw
- Massachusetts General Hospital Harvard Medical School Boston MA USA
| | | |
Collapse
|
49
|
Scott MR, Schultz AP, Buckley RF, Chou HL, Hampton OL, Hanseeuw BJ, Jacobs HI, Properzi MJ, Rabin JS, Johnson KA, Sperling RA, Chhatwal JP. Associations of peak width of skeletonized mean diffusivity with cardiovascular disease risk and cognitive decline in clinically normal older adults. Alzheimers Dement 2020. [DOI: 10.1002/alz.043812] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Matthew R. Scott
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
| | - Aaron P. Schultz
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
| | - Rachel F. Buckley
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- University of Melbourne Melbourne Australia
- The Florey Institute of Neuroscience and Mental Health Parkville Australia
| | - Hsiang‐Chin Lori Chou
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
| | - Olivia L Hampton
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
| | - Bernard J Hanseeuw
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Department of Neurology University Hospital Saint‐Luc and University Institute of Neuroscience UC Louvain Louvain‐la‐Neuve Belgium
- Gordon Center for Medical Imaging Massachusetts General Hospital Harvard Medical School Boston MA USA
| | - Heidi I.L. Jacobs
- Gordon Center for Medical Imaging Massachusetts General Hospital Harvard Medical School Boston MA USA
- Division of Nuclear Medicine and Molecular Imaging Department of Radiology Massachusetts General Hospital/Harvard Medical School Boston MA USA
| | - Michael J. Properzi
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
| | - Jennifer S. Rabin
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Sunnybrook Research Institute Toronto ON Canada
| | - Keith A. Johnson
- Gordon Center for Medical Imaging Massachusetts General Hospital Harvard Medical School Boston MA USA
- Division of Nuclear Medicine and Molecular Imaging Department of Radiology Massachusetts General Hospital/Harvard Medical School Boston MA USA
| | | | - Jasmeer P. Chhatwal
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
| |
Collapse
|
50
|
Rodriguez‐Vieitez E, Montal V, Sepulcre J, Lois C, Hanseeuw B, Vilaplana E, Schultz AP, Properzi MJ, Scott MR, Fortea J, Johnson KA, Sperling RA, Vannini P. The relationship between cortical microstructural changes and
in vivo
amyloid‐β and tau in aging and preclinical Alzheimer's disease. Alzheimers Dement 2020. [DOI: 10.1002/alz.041626] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Elena Rodriguez‐Vieitez
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Karolinska Institutet Stockholm Sweden
| | - Victor Montal
- Hospital de la Santa Creu i Sant Pau Barcelona Spain
- Centre of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED) Madrid Spain
| | - Jorge Sepulcre
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
| | - Cristina Lois
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
| | - Bernard Hanseeuw
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Saint Luc University Hospital Université Catholique de Louvain Brussels Belgium
| | - Eduard Vilaplana
- Hospital de la Santa Creu i Sant Pau Barcelona Spain
- Centre of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED) Madrid Spain
| | - Aaron P Schultz
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
| | - Michael J Properzi
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
| | - Matthew R Scott
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
| | - Juan Fortea
- Hospital de la Santa Creu i Sant Pau Barcelona Spain
- Alzheimer Down Unit Barcelona Spain
| | - Keith A Johnson
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
| | - Reisa A Sperling
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Brigham and Women's Hospital Harvard Medical School Boston MA USA
| | - Patrizia Vannini
- Massachusetts General Hospital Harvard Medical School Boston MA USA
- Athinoula A. Martinos Center for Biomedical Imaging Charlestown MA USA
- Brigham and Women's Hospital Harvard Medical School Boston MA USA
| |
Collapse
|